(9R,16R,17R)-9-Fluoro-11,17-dihydroxy-17-(2-hydroxy-acetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-cyclopenta[a]phenanthren-3-one

ID: ALA384467

Chembl Id: CHEMBL384467

Cas Number: 50-02-2

PubChem CID: 5743

Product Number: D129702

Max Phase: Approved

First Approval: 1958

Molecular Formula: C22H29FO5

Molecular Weight: 392.47

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Decadron-LA | Dexacen-4 | Dexacort | Dexair | Dexamethasone | Dexycu | Fluormethylprednisolone | Mymethasone | Neodecadron | ISV-305 | NSC-34521 | OTO-104 | dexamethasone|50-02-2|Decadron|Maxidex|Hexadecadrol|Dexamethazone|Dexasone|Hexadrol|Aeroseb-Dex|Fluormethylprednisolone|Desametasone|Superprednol|Visumetazone|Cortisumman|Decaderm|Decaspray|Dexacortal|Dexacortin|Gammacorten|Millicorten|Oradexon|Auxiron|Calonat|Dexason|Dexone|Prednisolone F|Dectancyl|Deltafluorene|Desamethasone|Desameton|FortShow More

Trade Names(32): Aeroseb-dex | Dalalone | Decaderm | Decadron | Decadron-75 | Decaspray | Dexacortisyl | Dexafree | Dexamethasone | Dexamethasone intensol | Dexone | Dexone 0.5 | Dexone 0.75 | Dexone 1.5 | Dexone 4 | Dexsol | Dextenza | Dexycu kit | Dropodex | Gppe ear spy | Hemady | Hexadrol | Kortico Injection | Martapan | Maxidex | Maxitrol | Oradexon | Otomize | Ozurdex | Sofradex | Spersadex comp | Tobradex

Canonical SMILES:  C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

Standard InChI:  InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1

Standard InChI Key:  UREBDLICKHMUKA-CXSFZGCWSA-N

Alternative Forms

  1. Parent:

    ALA384467

    DEXAMETHASONE

Associated Targets(Human)

ALB Tchem Serum albumin (2651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
N9 (414 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor (3070 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C2 Tclin Mineralocorticoid receptor (2134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HFF (3142 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Skin (286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGAL Tclin Intercellular adhesion molecule (ICAM-1), Integrin alpha-L/beta-2 (760 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JUN Tchem Proto-oncogene c-JUN (434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PBMC (10003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatocyte (2737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lymphoblastoid cell (5959 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TSHR Tclin Thyroid stimulating hormone receptor (29986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMC1 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFE2L2 Tchem Nuclear factor erythroid 2-related factor 2 (95332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATAD5 Tbio ATPase family AAA domain-containing protein 5 (122566 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2A6 Tchem Cytochrome P450 2A6 (2861 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CBX1 Tbio Chromobox protein homolog 1 (92434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RGS4 Tchem Regulator of G-protein signaling 4 (13867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARD Tchem Peroxisome proliferator-activated receptor delta (6293 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1H4 Tclin Bile acid receptor FXR (6228 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2B Tclin Alpha-2b adrenergic receptor (4412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR2 Tchem Angiotensin II type 2 (AT-2) receptor (2549 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BDKRB2 Tclin Bradykinin B2 receptor (3970 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR2 Tchem C-C chemokine receptor type 2 (5628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR4 Tclin C-C chemokine receptor type 4 (2819 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR5 Tclin C-C chemokine receptor type 5 (5640 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCR1 Tchem Interleukin-8 receptor A (2256 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCR2 Tchem Interleukin-8 receptor B (3491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCKAR Tclin Cholecystokinin A receptor (4460 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2E1 Tchem Cytochrome P450 2E1 (2174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor beta (9272 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYSLTR1 Tclin Cysteinyl leukotriene receptor 1 (2118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC3R Tchem Melanocortin receptor 3 (5659 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC4R Tclin Melanocortin receptor 4 (10016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MC5R Tchem Melanocortin receptor 5 (4283 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (7750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (6041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM5 Tclin Muscarinic acetylcholine receptor M5 (4677 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NPY1R Tchem Neuropeptide Y receptor type 1 (5019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NPY2R Tchem Neuropeptide Y receptor type 2 (3731 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTAFR Tchem Platelet activating factor receptor (2575 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CASP1 Tchem Caspase-1 (6235 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSG Tchem Cathepsin G (2304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ELANE Tclin Leukocyte elastase (8173 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCA Tchem Protein kinase C alpha (5923 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPP3CA Tchem Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform (1831 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FYN Tclin Tyrosine-protein kinase FYN (5308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERBB2 Tclin Receptor protein-tyrosine kinase erbB-2 (7851 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTPRC Tchem Leukocyte common antigen (2317 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR6 Tchem Serotonin 6 (5-HT6) receptor (9749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SIGMAR1 Tclin Sigma opioid receptor (6358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TACR1 Tclin Neurokinin 1 receptor (6273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TACR2 Tchem Neurokinin 2 receptor (3341 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXAS1 Tchem Thromboxane-A synthase (3355 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor 1 (6262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VIPR1 Tchem Vasoactive intestinal polypeptide receptor 1 (1904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SN12C (47755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H23 (49055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHN (49357 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-92 (41141 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-539 (44845 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Malme-3M (44254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-251 (51189 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-5 (45555 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-19 (46794 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SR (39847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TK-10 (45540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
M19-MEL (15326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW-620 (52400 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H522 (44358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
XF498 (12972 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
M14 (47487 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H322M (45589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-4 (44535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOX IMVI (44321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM-20L2 (14967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-75 (44215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-15 (51914 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-268 (49410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EKVX (44102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DMS-114 (15429 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LXFL 529 (14112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-62 (47335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGROV-1 (47897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UACC-257 (46019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNB-78 (14240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DLD-1 (17511 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H226 (44470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COLO 205 (50209 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO1A2 Tchem Solute carrier organic anion transporter family member 1A2 (104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO2B1 Tchem Solute carrier organic anion transporter family member 2B1 (580 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 (2517 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLCO1B1 Tchem Solute carrier organic anion transporter family member 1B1 (2672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC47A1 Tchem Multidrug and toxin extrusion protein 1 (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RELA Tchem Nuclear factor NF-kappa-B p65 subunit (627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TARDBP Tchem TAR DNA-binding protein 43 (40113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 (345557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IDH1 Tclin Isocitrate dehydrogenase [NADP] cytoplasmic (40980 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
APEX1 Tchem DNA-(apurinic or apyrimidinic site) lyase (38016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (7708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB11 Tchem Bile salt export pump (2311 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2J2 Tchem Cytochrome P450 2J2 (258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TNF Tclin TNF-alpha (1897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHX2 Tchem Epoxide hydratase (3844 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC2 Tchem Canalicular multispecific organic anion transporter 1 (1191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC3 Tbio Canalicular multispecific organic anion transporter 2 (718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC4 Tchem Multidrug resistance-associated protein 4 (785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARGC1A Tbio Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FPR2 Tchem Lipoxin A4 receptor (3472 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
REH (364 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U2OS (164939 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fibroblast (163371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRPF1 Tchem Peregrin (2217 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1D Tchem Casein kinase I delta (4546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR3 Tclin Fibroblast growth factor receptor 3 (7811 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TRIM24 Tchem Transcription intermediary factor 1-alpha (2087 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CX3CR1 Tchem C-X3-C chemokine receptor 1 (1686 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FFAR4 Tchem G-protein coupled receptor 120 (2999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADGRF1 Tbio Adhesion G-protein coupled receptor F1 (1591 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C5AR1 Tclin C5a anaphylatoxin chemotactic receptor (2677 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GLP1R Tclin Glucagon-like peptide 1 receptor (111429 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
APLNR Tchem Apelin receptor (3301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GPR35 Tchem G-protein coupled receptor 35 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GPR119 Tclin Glucose-dependent insulinotropic receptor (4762 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
S1PR1 Tclin Sphingosine 1-phosphate receptor Edg-1 (5806 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GES1 (603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G2A Tchem Phospholipase A2 group IIA (1079 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRNA4 Tclin Neuronal acetylcholine receptor protein alpha-4 subunit (1265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC29A1 Tclin Equilibrative nucleoside transporter 1 (1711 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCKBR Tclin Cholecystokinin B receptor (3550 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GHSR Tclin Ghrelin receptor (6229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4D Tclin Phosphodiesterase 4D (3546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1I2 Tchem Pregnane X receptor (6667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MLNR Tchem Motilin receptor (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cavia porcellus (23802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nr1i3 Constitutive androstane receptor (427 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sus scrofa (849 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nr3c1 Glucocorticoid receptor (1330 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ar Androgen Receptor (5522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nr3c2 Mineralocorticoid receptor (505 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pla2g1b Phospholipase A2 group 1B (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Prostaglandin G/H synthase (cyclooxygenase) (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Alox5 Arachidonate 5-lipoxygenase (2865 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774 (3120 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G1B Phospholipase A2 group 1B (227 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Cyclooxygenase (304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb1a P-glycoprotein 3 (492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb1b P-glycoprotein 1 (174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Syrian golden hamster (1610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW (181 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ccr4 C-C chemokine receptor type 4 (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.A1 (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatocyte (2621 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHO (4503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Esr1 Estrogen receptor alpha (180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pgr Progesterone receptor (248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.1 (238 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fabp1 Fatty acid-binding protein, liver (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Maoa Monoamine oxidase A (498 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Maob Monoamine oxidase B (346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei rhodesiense (7991 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei (78846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trichomonas vaginalis (2376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Toxoplasma gondii (4585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pneumocystis carinii (749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania mexicana (936 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania major (2877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania infantum (5912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania donovani (89745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania amazonensis (3813 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Entamoeba histolytica (2676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptosporidium parvum (1150 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Saccharomyces cerevisiae (19171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Luciferin 4-monooxygenase (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Alpha-1b adrenergic receptor (2470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Akr1b1 Aldose reductase (4007 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Glra2 Glycine receptor (1745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Insr Insulin receptor (1750 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LTC4S Leukotriene C4 synthase (1746 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX15 Arachidonate 15-lipoxygenase (2064 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos1 Nitric-oxide synthase, brain (2987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Progesterone receptor (1742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE Angiotensin-converting enzyme (2863 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr1a Serotonin 1a (5-HT1a) receptor (8655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Htr1b Serotonin 1b (5-HT1b) receptor (2343 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR4 Serotonin 4 (5-HT4) receptor (2870 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcc2 Canalicular multispecific organic anion transporter 1 (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slco1a1 Solute carrier organic anion transporter family member 1A1 (265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb11 Bile salt export pump (133 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slco1a3 Solute carrier organic anion transporter family member 1A3 (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slco1a4 Solute carrier organic anion transporter family member 1A4 (114 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mdr1a Multidrug resistance protein 1a (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb1 Multidrug resistance protein 1 (79 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nr1i2 Nuclear receptor subfamily 1 group I member 2 (641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rela Transcription factor p65 (175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jun Transcription factor AP-1 (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nr3c1 Glucocorticoid receptor (140 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nlrp3 NACHT, LRR and PYD domains-containing protein 3 (641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RBL-2H3 (1162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pparg Peroxisome proliferator-activated receptor gamma (748 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Danio rerio (3092 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BV-2 (3710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Splenocyte (1641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.2 (197 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Peritoneal macrophage (1554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
B-cell line (200 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chikungunya virus (1339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cacna1c Voltage-gated L-type calcium channel alpha-1C subunit (1321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin1 Glutamate (NMDA) receptor subunit zeta 1 (2166 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gabra1 GABA receptor alpha-1 subunit (2848 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ptgs1 Cyclooxygenase-1 (1373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: YesChemical Probe: NoParenteral: Yes
Molecule Type: Small moleculeTopical: YesFirst In Class: NoBlack Box: No
Chirality: YesAvailability: YesProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 392.47Molecular Weight (Monoisotopic): 392.1999AlogP: 1.90#Rotatable Bonds: 2
Polar Surface Area: 94.83Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.42CX Basic pKa: CX LogP: 1.68CX LogD: 1.68
Aromatic Rings: Heavy Atoms: 28QED Weighted: 0.67Np Likeness Score: 2.21

References

1. Kansy M, Senner F, Gubernator K..  (1998)  Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes.,  41  (7): [PMID:9544199] [10.1021/jm970530e]
2. Honda T, Honda Y, Favaloro FG, Gribble GW, Suh N, Place AE, Rendi MH, Sporn MB..  (2002)  A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production.,  12  (7): [PMID:11909709] [10.1016/s0960-894x(02)00105-1]
3. Jorgensen WL, Duffy EM..  (2000)  Prediction of drug solubility from Monte Carlo simulations.,  10  (11): [PMID:10866370] [10.1016/s0960-894x(00)00172-4]
4. Ojasoo T, Doré JC, Gilbert J, Raynaud JP..  (1988)  Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis.,  31  (6): [PMID:2897467] [10.1021/jm00401a015]
5. Hoyte RM, Borderon K, Bryson K, Allen R, Hochberg RB, Brown TJ..  (1994)  Synthesis and evaluation of 7 alpha-iodo-5 alpha-dihydrotestosterone as a potential radioligand for androgen receptor.,  37  (8): [PMID:8164266] [10.1021/jm00034a022]
6. Lombardo F, Obach RS, Shalaeva MY, Gao F..  (2004)  Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.,  47  (5): [PMID:14971904] [10.1021/jm030408h]
7. Maxwell JR, Wasdahl DA, Wolfson AC, Stenberg VI..  (1984)  Synthesis of 5-aryl-2H-tetrazoles, 5-aryl-2H-tetrazole-2-acetic acids, and [(4-phenyl-5-aryl-4H-1,2,4-triazol-3-yl)thio]acetic acids as possible superoxide scavengers and antiinflammatory agents.,  27  (12): [PMID:6094808] [10.1021/jm00378a007]
8. Fujita M, Seki T, Inada H, Ikeda N..  (2002)  Synthesis and bioactivities of novel 4,5,6,7-tetrahydrothieno[2,3-c]pyridines as inhibitors of tumor necrosis factor-alpha (TNF-alpha) production.,  12  (12): [PMID:12039573] [10.1016/s0960-894x(02)00228-7]
9. Andrews PR, Craik DJ, Martin JL..  (1984)  Functional group contributions to drug-receptor interactions.,  27  (12): [PMID:6094812] [10.1021/jm00378a021]
10. Schwab D, Fischer H, Tabatabaei A, Poli S, Huwyler J..  (2003)  Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.,  46  (9): [PMID:12699389] [10.1021/jm021012t]
11. Hamann LG, Farmer LJ, Johnson MG, Bender SL, Mais DE, Wang MW, Crombie D, Goldman ME, Jones TK..  (1996)  Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether.,  39  (9): [PMID:8627601] [10.1021/jm950747d]
12. Fujita M, Seki T, Ikeda N..  (2002)  Synthesis and bioactivities of novel bicyclic thiophenes and 4,5,6,7-tetrahydrothieno[2,3-c]pyridines as inhibitors of tumor necrosis factor-alpha (TNF-alpha) production.,  12  (15): [PMID:12113803] [10.1016/s0960-894x(02)00332-3]
13. Wilkerson WW, Galbraith W, DeLucca I, Harris RR.  (1993)  Topical antiinflammatory dehydroabietylamine derivatives. IV,  (10): [10.1016/S0960-894X(01)81022-2]
14. Stouch TR, Jurs PC..  (1986)  Computer-aided studies of the structure-activity relationships between the structure of some steroids and their antiinflammatory activity.,  29  (11): [PMID:3783574] [10.1021/jm00161a001]
15. Buckle DR, Foster KA, Taylor JF, Tedder JM, Thody VE, Webster RA, Bermudez J, Markwell RE, Smith SA..  (1987)  Novel 1H-benzimidazol-4-ols with potent 5-lipoxygenase inhibitory activity.,  30  (12): [PMID:3681891] [10.1021/jm00395a007]
16. Claire M, Faraj H, Grassy G, Aumelas A, Rondot A, Auzou G..  (1993)  Synthesis of new 11 beta-substituted spirolactone derivatives. Relationship with affinity for mineralocorticoid and glucocorticoid receptors.,  36  (16): [PMID:8360885] [10.1021/jm00068a018]
17. Cheng JF, Chen M, Wallace D, Tith S, Arrhenius T, Kashiwagi H, Ono Y, Ishikawa A, Sato H, Kozono T, Sato H, Nadzan AM..  (2004)  Discovery and structure-activity relationship of coumarin derivatives as TNF-alpha inhibitors.,  14  (10): [PMID:15109623] [10.1016/j.bmcl.2004.03.022]
18. Lombardo F, Shalaeva MY, Tupper KA, Gao F..  (2001)  ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.,  44  (15): [PMID:11448232] [10.1021/jm0100990]
19. Yoshida F, Topliss JG..  (2000)  QSAR model for drug human oral bioavailability.,  43  (13): [PMID:10891117] [10.1021/jm0000564]
20. Friend DR, Chang GW..  (1984)  A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria.,  27  (3): [PMID:6699871] [10.1021/jm00369a005]
21. Honda T, Rounds BV, Gribble GW, Suh N, Wang Y, Sporn MB..  (1998)  Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages.,  (19): [PMID:9873608] [10.1016/s0960-894x(98)00479-x]
22. Lombardo F, Obach RS, Shalaeva MY, Gao F..  (2002)  Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.,  45  (13): [PMID:12061889] [10.1021/jm0200409]
23. Lombardo F, Shalaeva MY, Tupper KA, Gao F, Abraham MH..  (2000)  ElogPoct: a tool for lipophilicity determination in drug discovery.,  43  (15): [PMID:10956200] [10.1021/jm0000822]
24. Akahoshi F, Takeda S, Okada T, Kajii M, Nishimura H, Sugiura M, Inoue Y, Fukaya C, Naito Y, Imagawa T, Nakamura N..  (1998)  Synthesis and pharmacological activity of triazolo[1,5-a]triazine derivatives inhibiting eosinophilia.,  41  (16): [PMID:9685237] [10.1021/jm970759u]
25. Naito Y, Akahoshi F, Takeda S, Okada T, Kajii M, Nishimura H, Sugiura M, Fukaya C, Kagitani Y..  (1996)  Synthesis and pharmacological activity of triazole derivatives inhibiting eosinophilia.,  39  (15): [PMID:8709136] [10.1021/jm9507993]
26. Bodor N, Harget AJ, Phillips EW..  (1983)  Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach.,  26  (3): [PMID:6827553] [10.1021/jm00357a003]
27. Kumar V, Bell MR, Wetzel JR, Herrmann JL, McGarry R, Schane HP, Winneker RC, Snyder BW, Anzalone AJ..  (1993)  Non-steroidal glucocorticoid-like substances: receptor binding and in vivo activity.,  36  (22): [PMID:8230118] [10.1021/jm00074a008]
28. Honda T, Rounds BV, Bore L, Favaloro FG, Gribble GW, Suh N, Wang Y, Spor MB..  (1999)  Novel synthetic oleanane triterpenoids: a series of highly active inhibitors of nitric oxide production in mouse macrophages.,  (24): [PMID:10617085] [10.1016/s0960-894x(99)00623-x]
29. Awale S, Tezuka Y, Banskota AH, Kadota S..  (2003)  Siphonols A-E: novel nitric oxide inhibitors from Orthosiphon stamineus of Indonesia.,  13  (1): [PMID:12467611] [10.1016/s0960-894x(02)00854-5]
30. Honda T, Rounds BV, Bore L, Finlay HJ, Favaloro FG, Suh N, Wang Y, Sporn MB, Gribble GW..  (2000)  Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages.,  43  (22): [PMID:11063620] [10.1021/jm0002230]
31. Chen YL, Lu CM, Chen IL, Tsao LT, Wang JP..  (2002)  Synthesis and antiinflammatory evaluation of 9-anilinoacridine and 9-phenoxyacridine derivatives.,  45  (21): [PMID:12361395] [10.1021/jm020102v]
32. Jyrkkärinne J, Mäkinen J, Gynther J, Savolainen H, Poso A, Honkakoski P..  (2003)  Molecular determinants of steroid inhibition for the mouse constitutive androstane receptor.,  46  (22): [PMID:14561088] [10.1021/jm030861t]
33. Quintela JM, Peinador C, González LM, Riguera R, Rioja I, Terencio MC, Ubeda A, Alcaraz MJ..  (1999)  Synthesis and pharmacological evaluation of some 8-cyanopyrido[3', 2':4,5]thieno[3,2-d]triazine derivatives as inhibitors of nitric oxide and eicosanoid biosynthesis.,  42  (22): [PMID:10579834] [10.1021/jm991085l]
34. Hoyte RM, Zhang JX, Lerum R, Oluyemi A, Persaud P, O'Connor C, Labaree DC, Hochberg RB..  (2002)  Synthesis of halogen-substituted pyridyl and pyrimidyl derivatives of [3,2-c]pyrazolo corticosteroids: strategies for the development of glucocorticoid receptor mediated imaging agents.,  45  (24): [PMID:12431067] [10.1021/jm0202775]
35. Tobe M, Isobe Y, Tomizawa H, Matsumoto M, Obara F, Nagasaki T, Hayashi H..  (2001)  Structure-activity relationships of quinazoline derivatives: dual-acting compounds with inhibitory activities toward both TNF-alpha production and T cell proliferation.,  11  (4): [PMID:11229767] [10.1016/s0960-894x(00)00718-6]
36. Lüllmann H, Timmermans PB, Weikert GM, Ziegler A..  (1980)  Accumulation of drugs by guinea pig isolated atria. Quantitative correlations.,  23  (5): [PMID:7381857] [10.1021/jm00179a017]
37. Friend DR, Chang GW..  (1985)  Drug glycosides: potential prodrugs for colon-specific drug delivery.,  28  (1): [PMID:3965714] [10.1021/jm00379a012]
38. Menciu C, Duflos M, Fouchard F, Le Baut G, Emig P, Achterrath U, Szelenyi I, Nickel B, Schmidt J, Kutscher B, Günther E..  (1999)  New N-(pyridin-4-yl)-(indol-3-yl)acetamides and propanamides as antiallergic agents.,  42  (4): [PMID:10052971] [10.1021/jm981079+]
39. Ponpipom MM, Bugianesi RL, Blake TJ..  (1987)  Inhibition of delayed hypersensitivity reactions by cinnamyl 1-thioglycosides.,  30  (4): [PMID:3494125] [10.1021/jm00387a021]
40. Wilkerson W, DeLucca I, Galbraith W, Harris R, Kerr J.  (1993)  Antiinflammatory -benzeneethanamines. III,  (4): [10.1016/S0960-894X(01)81260-9]
41. Konopelski JP, Djerassi C, Raynaud JP..  (1980)  Synthesis and biochemical screening of phenylselenium-substituted steroid hormones.,  23  (7): [PMID:7401101] [10.1021/jm00181a004]
42. Self CR, Barber WE, Machin PJ, Osbond JM, Smithen CE, Tong BP, Wickens JC, Bloxham DP, Bradshaw D, Cashin CH..  (1991)  Romazarit: a potential disease-modifying antirheumatic drug.,  34  (2): [PMID:1995900] [10.1021/jm00106a044]
43. Scholz D, Baumann K, Grassberger M, Wolff-Winiski B, Rihs G, Walter H, Meingassner JG..  (2004)  Synthesis of dammarane-type triterpenoids with anti-inflammatory activity in vivo.,  14  (11): [PMID:15125973] [10.1016/j.bmcl.2004.02.104]
44. Dassonville A, Bretéché A, Evano J, Duflos M, le Baut G, Grimaud N, Petit JY..  (2004)  New N-pyridinyl(methyl)-indolalkanamides acting as topical inflammation inhibitors.,  14  (21): [PMID:15454241] [10.1016/j.bmcl.2004.07.057]
45. Wang YH, Li Y, Li YH, Yang SL, Yang L..  (2005)  Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.,  15  (18): [PMID:15990295] [10.1016/j.bmcl.2005.06.015]
46. Barker M, Clackers M, Demaine DA, Humphreys D, Johnston MJ, Jones HT, Pacquet F, Pritchard JM, Salter M, Shanahan SE, Skone PA, Vinader VM, Uings I, McLay IM, Macdonald SJ..  (2005)  Design and synthesis of new nonsteroidal glucocorticoid modulators through application of an "agreement docking" method.,  48  (14): [PMID:15999989] [10.1021/jm050345y]
47. Betageri R, Zhang Y, Zindell RM, Kuzmich D, Kirrane TM, Bentzien J, Cardozo M, Capolino AJ, Fadra TN, Nelson RM, Paw Z, Shih DT, Shih CK, Zuvela-Jelaska L, Nabozny G, Thomson DS..  (2005)  Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand.,  15  (21): [PMID:16112571] [10.1016/j.bmcl.2005.07.025]
48. Lill MA, Winiger F, Vedani A, Ernst B..  (2005)  Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.,  48  (18): [PMID:16134935] [10.1021/jm050403f]
49. Ottaviani G, Martel S, Carrupt PA..  (2006)  Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.,  49  (13): [PMID:16789751] [10.1021/jm060230+]
50. Kahn MG, Konde E, Dossou F, Labaree DC, Hochberg RB, Hoyte RM..  (2006)  Microwave-enhanced nucleophilic fluorination in the synthesis of fluoropyridyl derivatives of [3,2-c]pyrazolo-corticosteroids, potential glucocorticoid receptor-mediated imaging agents.,  16  (13): [PMID:16644222] [10.1016/j.bmcl.2006.04.008]
51. Barker M, Clackers M, Copley R, Demaine DA, Humphreys D, Inglis GG, Johnston MJ, Jones HT, Haase MV, House D, Loiseau R, Nisbet L, Pacquet F, Skone PA, Shanahan SE, Tape D, Vinader VM, Washington M, Uings I, Upton R, McLay IM, Macdonald SJ..  (2006)  Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.,  49  (14): [PMID:16821781] [10.1021/jm060302x]
52. Bürli RW, Xu H, Zou X, Muller K, Golden J, Frohn M, Adlam M, Plant MH, Wong M, McElvain M, Regal K, Viswanadhan VN, Tagari P, Hungate R..  (2006)  Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents.,  16  (14): [PMID:16697190] [10.1016/j.bmcl.2006.04.068]
53. Regan J, Lee TW, Zindell RM, Bekkali Y, Bentzien J, Gilmore T, Hammach A, Kirrane TM, Kukulka AJ, Kuzmich D, Nelson RM, Proudfoot JR, Ralph M, Pelletier J, Souza D, Zuvela-Jelaska L, Nabozny G, Thomson DS..  (2006)  Quinol-4-ones as steroid A-ring mimetics in nonsteroidal dissociated glucocorticoid agonists.,  49  (26): [PMID:17181172] [10.1021/jm061273t]
54. Greco MN, Hawkins MJ, Powell ET, Almond HR, de Garavilla L, Hall J, Minor LK, Wang Y, Corcoran TW, Di Cera E, Cantwell AM, Savvides SN, Damiano BP, Maryanoff BE..  (2007)  Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase.,  50  (8): [PMID:17361995] [10.1021/jm0700619]
55. Honda T, Sundararajan C, Yoshizawa H, Su X, Honda Y, Liby KT, Sporn MB, Gribble GW..  (2007)  Novel tricyclic compounds having acetylene groups at C-8a and cyano enones in rings A and C: highly potent anti-inflammatory and cytoprotective agents.,  50  (8): [PMID:17367124] [10.1021/jm070141c]
56. Guerrero MD, Aquino M, Bruno I, Terencio MC, Paya M, Riccio R, Gomez-Paloma L..  (2007)  Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression.,  50  (9): [PMID:17407277] [10.1021/jm0700823]
57. Fujikawa M, Nakao K, Shimizu R, Akamatsu M..  (2007)  QSAR study on permeability of hydrophobic compounds with artificial membranes.,  15  (11): [PMID:17418579] [10.1016/j.bmc.2007.03.040]
58. Bruno O, Brullo C, Bondavalli F, Schenone S, Ranise A, Arduino N, Bertolotto MB, Montecucco F, Ottonello L, Dallegri F, Tognolini M, Ballabeni V, Bertoni S, Barocelli E..  (2007)  Synthesis and biological evaluation of N-pyrazolyl-N'-alkyl/benzyl/phenylureas: a new class of potent inhibitors of interleukin 8-induced neutrophil chemotaxis.,  50  (15): [PMID:17608466] [10.1021/jm0704402]
59. Barnes MJ, Conroy R, Miller DJ, Mills JS, Montana JG, Pooni PK, Showell GA, Walsh LM, Warneck JB..  (2007)  Trimethylsilylpyrazoles as novel inhibitors of p38 MAP kinase: a new use of silicon bioisosteres in medicinal chemistry.,  17  (2): [PMID:17095218] [10.1016/j.bmcl.2006.10.044]
60. Purandare AV, Wan H, Somerville JE, Burke C, Vaccaro W, Yang X, McIntyre KW, Poss MA..  (2007)  Core exploration in optimization of chemokine receptor CCR4 antagonists.,  17  (3): [PMID:17098428] [10.1016/j.bmcl.2006.10.091]
61. Marshall DR, Rodriguez G, Thomson DS, Nelson R, Capolina A..  (2007)  Alpha-methyltryptamine sulfonamide derivatives as novel glucocorticoid receptor ligands.,  17  (2): [PMID:17118655] [10.1016/j.bmcl.2006.10.058]
62. Hudson AR, Roach SL, Higuchi RI, Phillips DP, Bissonnette RP, Lamph WW, Yen J, Li Y, Adams ME, Valdez LJ, Vassar A, Cuervo C, Kallel EA, Gharbaoui CJ, Mais DE, Miner JN, Marschke KB, Rungta D, Negro-Vilar A, Zhi L..  (2007)  Synthesis and characterization of nonsteroidal glucocorticoid receptor modulators for multiple myeloma.,  50  (19): [PMID:17705362] [10.1021/jm070370z]
63. Clackers M, Coe DM, Demaine DA, Hardy GW, Humphreys D, Inglis GG, Johnston MJ, Jones HT, House D, Loiseau R, Minick DJ, Skone PA, Uings I, McLay IM, Macdonald SJ..  (2007)  Non-steroidal glucocorticoid agonists: the discovery of aryl pyrazoles as A-ring mimetics.,  17  (17): [PMID:17616395] [10.1016/j.bmcl.2007.06.066]
64. Kuzmich D, Kirrane T, Proudfoot J, Bekkali Y, Zindell R, Beck L, Nelson R, Shih CK, Kukulka AJ, Paw Z, Reilly P, Deleon R, Cardozo M, Nabozny G, Thomson D..  (2007)  Identification of dissociated non-steroidal glucocorticoid receptor agonists.,  17  (18): [PMID:17692519] [10.1016/j.bmcl.2007.07.031]
65. Ramírez JA, Bruttomesso AC, Michelini FM, Acebedo SL, Alché LE, Galagovsky LR..  (2007)  Syntheses of immunomodulating androstanes and stigmastanes: comparison of their TNF-alpha inhibitory activity.,  15  (24): [PMID:17892941] [10.1016/j.bmc.2007.09.012]
66. Biggadike K, Boudjelal M, Clackers M, Coe DM, Demaine DA, Hardy GW, Humphreys D, Inglis GG, Johnston MJ, Jones HT, House D, Loiseau R, Needham D, Skone PA, Uings I, Veitch G, Weingarten GG, McLay IM, Macdonald SJ..  (2007)  Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity.,  50  (26): [PMID:18038970] [10.1021/jm070778w]
67. Ottaviani G, Martel S, Carrupt PA..  (2007)  In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.,  50  (4): [PMID:17300161] [10.1021/jm0611105]
68. Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, Slegers G, Vander Heyden Y, Lambert J, Beetens J, De Spiegeleer B..  (2007)  Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.,  15  (22): [PMID:17827020] [10.1016/j.bmc.2007.07.050]
69. Chang SF, Yang LM, Lo CH, Liaw JH, Wang LH, Lin SJ..  (2008)  Microbial transformation of isosteviol and bioactivities against the glucocorticoid/androgen response elements.,  71  (1): [PMID:18177009] [10.1021/np070468g]
70. Miner JN, Ardecky B, Benbatoul K, Griffiths K, Larson CJ, Mais DE, Marschke K, Rosen J, Vajda E, Zhi L, Negro-Vilar A..  (2007)  Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile.,  104  (49): [PMID:18032610] [10.1073/pnas.0705517104]
71. Chang SF, Yang LM, Hsu FL, Hsu JY, Liaw JH, Lin SJ..  (2006)  Transformation of steviol-16alpha,17-epoxide by Streptomyces griseus and Cunninghamella bainieri.,  69  (10): [PMID:17067160] [10.1021/np0602564]
72. Kiso Y, Tohkin M, Hikino H..  (1983)  Assay method for antihepatotoxic activity using galactosamine-induced cytotoxicity in primary-cultured hepatocytes.,  46  (6): [PMID:6677713] [10.1021/np50030a003]
73. Cuéllar MJ, Giner RM, Recio MC, Just MJ, Máñez S, Cerdá M, Hostettmann K, Ríos JL..  (1997)  Zanhasaponins A and B, antiphospholipase A2 saponins from an antiinflammatory extract of Zanha africana root bark.,  60  (11): [PMID:9392883] [10.1021/np970221r]
74. Muhammad I, Bedir E, Khan SI, Tekwani BL, Khan IA, Takamatsu S, Pelletier J, Walker LA..  (2004)  A new antimalarial quassinoid from Simaba orinocensis.,  67  (5): [PMID:15165136] [10.1021/np030524n]
75. Day SH, Lin YC, Tsai ML, Tsao LT, Ko HH, Chung MI, Lee JC, Wang JP, Won SJ, Lin CN..  (2002)  Potent cytotoxic lignans from Justicia procumbens and their effects on nitric oxide and tumor necrosis factor-alpha production in mouse macrophages.,  65  (3): [PMID:11908984] [10.1021/np0101651]
76. Franklin PX, Pillai AD, Rathod PD, Yerande S, Nivsarkar M, Padh H, Vasu KK, Sudarsanam V..  (2008)  2-Amino-5-thiazolyl motif: a novel scaffold for designing anti-inflammatory agents of diverse structures.,  43  (1): [PMID:17467123] [10.1016/j.ejmech.2007.02.008]
77. Chuang S, Velkov T, Horne J, Porter CJ, Scanlon MJ..  (2008)  Characterization of the drug binding specificity of rat liver fatty acid binding protein.,  51  (13): [PMID:18533710] [10.1021/jm701192w]
78. Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F..  (2008)  Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.,  51  (21): [PMID:18834112] [10.1021/jm800656v]
79. Yang BV, Vaccaro W, Doweyko AM, Doweyko LM, Huynh T, Tortolani D, Nadler SG, McKay L, Somerville J, Holloway DA, Habte S, Weinstein DS, Barrish JC..  (2009)  Discovery of novel dihydro-9,10-ethano-anthracene carboxamides as glucocorticoid receptor modulators.,  19  (8): [PMID:19321341] [10.1016/j.bmcl.2009.03.006]
80. Máñez S, Recio MC, Gil I, Gómez C, Giner RM, Waterman PG, Ríos JL..  (1999)  A glycosyl analogue of diacylglycerol and other antiinflammatory constituents from Inula viscosa.,  62  (4): [PMID:10217718] [10.1021/np980132u]
81. Fox DJ, Reckless J, Lingard H, Warren S, Grainger DJ..  (2009)  Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors.,  52  (11): [PMID:19425597] [10.1021/jm900133w]
82. Cesarini S, Spallarossa A, Ranise A, Bruno O, Arduino N, Bertolotto M, Dallegri F, Tognolini M, Gobbetti T, Barocelli E..  (2009)  6-amino-4-oxo-1,3-diphenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonyl derivatives as a new class of potent inhibitors of Interleukin-8-induced neutrophil chemotaxis.,  17  (10): [PMID:19394230] [10.1016/j.bmc.2009.04.006]
83. Bruno O, Brullo C, Bondavalli F, Schenone S, Spisani S, Falzarano MS, Varani K, Barocelli E, Ballabeni V, Giorgio C, Tognolini M..  (2009)  1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors.,  17  (9): [PMID:19362486] [10.1016/j.bmc.2009.03.035]
84. Recio MC, Just MJ, Giner RM, Mañez S, Rios JL, Hostettmann K..  (1995)  Anti-inflammatory activity of saikosaponins from Heteromorpha trifoliata.,  58  (1): [PMID:7760072] [10.1021/np50115a023]
85. Kaileh M, Vanden Berghe W, Heyerick A, Horion J, Piette J, Libert C, De Keukeleire D, Essawi T, Haegeman G..  (2007)  Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity.,  282  (7): [PMID:17150968] [10.1074/jbc.m606728200]
86. Wassvik CM, Holmén AG, Draheim R, Artursson P, Bergström CA..  (2008)  Molecular characteristics for solid-state limited solubility.,  51  (10): [PMID:18396854] [10.1021/jm701587d]
87. Bharate SB, Mahajan TR, Gole YR, Nambiar M, Matan TT, Kulkarni-Almeida A, Balachandran S, Junjappa H, Balakrishnan A, Vishwakarma RA..  (2008)  Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-alpha and IL-6 inhibitors.,  16  (15): [PMID:18625560] [10.1016/j.bmc.2008.06.042]
88. Aquino M, Guerrero MD, Bruno I, Terencio MC, Paya M, Riccio R..  (2008)  Development of a second generation of inhibitors of microsomal prostaglandin E synthase 1 expression bearing the gamma-hydroxybutenolide scaffold.,  16  (19): [PMID:18790649] [10.1016/j.bmc.2008.08.001]
89. Bydal P, Luu-The V, Labrie F, Poirier D..  (2009)  Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.,  44  (2): [PMID:18472187] [10.1016/j.ejmech.2008.03.020]
90. Strangman WK, Kwon HC, Broide D, Jensen PR, Fenical W..  (2009)  Potent inhibitors of pro-inflammatory cytokine production produced by a marine-derived bacterium.,  52  (8): [PMID:19323483] [10.1021/jm801110j]
91. Awale S, Tezuka Y, Banskota AH, Adnyana IK, Kadota S..  (2003)  Nitric oxide inhibitory isopimarane-type diterpenes from Orthosiphon stamineus of Indonesia.,  66  (2): [PMID:12608860] [10.1021/np020455x]
92. Cao S, Low KN, Glover RP, Crasta SC, Ng S, Buss AD, Butler MS..  (2006)  Sundaicumones A and B, polyprenylated acylphloroglucinol derivatives from Calophyllumsundaicum with weak activity against the glucocorticoid receptor.,  69  (4): [PMID:16643060] [10.1021/np050528n]
93. Day SH, Wang JP, Won SJ, Lin CN..  (2001)  Bioactive constituents of the roots of Cynanchum atratum.,  64  (5): [PMID:11374953] [10.1021/np000428b]
94. Carroll AR, Addepalli R, Fechner G, Smith J, Guymer GP, Forster PI, Quinn RJ..  (2008)  Alkaloids from the Australian rainforest tree Ochrosia moorei.,  71  (6): [PMID:18412397] [10.1021/np070655e]
95. Tan NC, Yu P, Kwon YU, Kodadek T..  (2008)  High-throughput evaluation of relative cell permeability between peptoids and peptides.,  16  (11): [PMID:18490170] [10.1016/j.bmc.2008.04.074]
96. Pérez-Garrido A, Morales Helguera A, Abellán Guillén A, Cordeiro MN, Garrido Escudero A..  (2009)  Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.,  17  (2): [PMID:19056282] [10.1016/j.bmc.2008.11.040]
97. La Motta C, Sartini S, Mugnaini L, Salerno S, Simorini F, Taliani S, Marini AM, Da Settimo F, Lavecchia A, Novellino E, Antonioli L, Fornai M, Blandizzi C, Del Tacca M..  (2009)  Exploiting the pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors.,  52  (6): [PMID:19226143] [10.1021/jm801427r]
98. Akama T, Baker SJ, Zhang YK, Hernandez V, Zhou H, Sanders V, Freund Y, Kimura R, Maples KR, Plattner JJ..  (2009)  Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis.,  19  (8): [PMID:19303290] [10.1016/j.bmcl.2009.03.007]
99. Liu B, Kodadek T..  (2009)  Investigation of the relative cellular permeability of DNA-binding pyrrole-imidazole polyamides.,  52  (15): [PMID:19610652] [10.1021/jm9002999]
100. Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A..  (2009)  Physicochemical determinants of human renal clearance.,  52  (15): [PMID:19445515] [10.1021/jm900403j]
101. Nishizaki Y, Ishimoto Y, Hotta Y, Hosoda A, Yoshikawa H, Akamatsu M, Tamura H..  (2009)  Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.,  19  (16): [PMID:19592245] [10.1016/j.bmcl.2009.06.073]
102. Biggadike K, Caivano M, Clackers M, Coe DM, Hardy GW, Humphreys D, Jones HT, House D, Miles-Williams A, Skone PA, Uings I, Weller V, McLay IM, Macdonald SJ..  (2009)  Highly tractable, sub-nanomolar non-steroidal glucocorticoid receptor agonists.,  19  (16): [PMID:19592247] [10.1016/j.bmcl.2009.06.020]
103. Xiao HY, Wu DR, Malley MF, Gougoutas JZ, Habte SF, Cunningham MD, Somerville JE, Dodd JH, Barrish JC, Nadler SG, Dhar TG..  (2010)  Novel synthesis of the hexahydroimidazo[1,5b]isoquinoline scaffold: application to the synthesis of glucocorticoid receptor modulators.,  53  (3): [PMID:20047280] [10.1021/jm901551w]
104. Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD..  (2010)  Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.,  53  (3): [PMID:20070106] [10.1021/jm901371v]
105. Lee PH, Conradi R, Shanmugasundaram V..  (2010)  Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.,  20  (1): [PMID:19963379] [10.1016/j.bmcl.2009.11.039]
106. Du-Cuny L, Song Z, Moses S, Powis G, Mash EA, Meuillet EJ, Zhang S..  (2009)  Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.,  17  (19): [PMID:19734051] [10.1016/j.bmc.2009.08.022]
107. Chang SF, Chou BH, Yang LM, Hsu FL, Lin WK, Ho Y, Lin SJ..  (2009)  Microbial transformation of isosteviol oxime and the inhibitory effects on NF-kappaB and AP-1 activation in LPS-stimulated macrophages.,  17  (17): [PMID:19648015] [10.1016/j.bmc.2009.07.029]
108. Bandgar BP, Gawande SS, Bodade RG, Gawande NM, Khobragade CN..  (2009)  Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents.,  17  (24): [PMID:19896853] [10.1016/j.bmc.2009.10.035]
109. Chen CS, Tan CM, Huang CH, Chang LC, Wang JP, Cheng FC, Chern JW..  (2010)  Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.,  18  (2): [PMID:20056549] [10.1016/j.bmc.2009.12.008]
110. Bandgar BP, Gawande SS, Bodade RG, Totre JV, Khobragade CN..  (2010)  Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents.,  18  (3): [PMID:20064725] [10.1016/j.bmc.2009.11.066]
111. Li G, Wang D, Sun M, Li G, Hu J, Zhang Y, Yuan Y, Ji H, Chen N, Liu G..  (2010)  Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.,  53  (4): [PMID:20099827] [10.1021/jm901652p]
112. Bandgar BP, Gawande SS..  (2010)  Synthesis and biological screening of a combinatorial library of beta-chlorovinyl chalcones as anticancer, anti-inflammatory and antimicrobial agents.,  18  (5): [PMID:20138527] [10.1016/j.bmc.2009.12.077]
113. Yang CL, Chik SC, Li JC, Cheung BK, Lau AS..  (2009)  Identification of the bioactive constituent and its mechanisms of action in mediating the anti-inflammatory effects of black cohosh and related Cimicifuga species on human primary blood macrophages.,  52  (21): [PMID:19835377] [10.1021/jm9006164]
114. Roll DM, Barbieri LR, Bigelis R, McDonald LA, Arias DA, Chang LP, Singh MP, Luckman SW, Berrodin TJ, Yudt MR..  (2009)  The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144.,  72  (11): [PMID:19863083] [10.1021/np9004882]
115. Sui X, Sun J, Li H, Wang Y, Liu J, Liu X, Zhang W, Chen L, He Z..  (2009)  Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.,  44  (11): [PMID:19586686] [10.1016/j.ejmech.2009.06.004]
116. Zhang YK, Plattner JJ, Akama T, Baker SJ, Hernandez VS, Sanders V, Freund Y, Kimura R, Bu W, Hold KM, Lu XS..  (2010)  Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application.,  20  (7): [PMID:20188549] [10.1016/j.bmcl.2010.02.010]
117. Bandgar BP, Patil SA, Totre JV, Korbad BL, Gacche RN, Hote BS, Jalde SS, Chavan HV..  (2010)  Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity.,  20  (7): [PMID:20207143] [10.1016/j.bmcl.2010.02.001]
118. Onnis V, Kinsella GK, Carta G, Jagoe WN, Price T, Williams DC, Fayne D, Lloyd DG..  (2010)  Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators.,  53  (8): [PMID:20334371] [10.1021/jm901452y]
119. Guerra A, Campillo NE, Páez JA..  (2010)  Neural computational prediction of oral drug absorption based on CODES 2D descriptors.,  45  (3): [PMID:20022146] [10.1016/j.ejmech.2009.11.034]
120. Zhou HB, Lee JH, Mayne CG, Carlson KE, Katzenellenbogen JA..  (2010)  Imaging progesterone receptor in breast tumors: synthesis and receptor binding affinity of fluoroalkyl-substituted analogues of tanaproget.,  53  (8): [PMID:20355713] [10.1021/jm100052k]
121. Avdeef A, Tam KY..  (2010)  How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?,  53  (9): [PMID:20373811] [10.1021/jm901846t]
122. Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA..  (2010)  5-Functionalized indazoles as glucocorticoid receptor agonists.,  20  (10): [PMID:20427184] [10.1016/j.bmcl.2010.04.012]
123. Yates CM, Brown PJ, Stewart EL, Patten C, Austin RJ, Holt JA, Maglich JM, Angell DC, Sasse RZ, Taylor SJ, Uings IJ, Trump RP..  (2010)  Structure guided design of 5-arylindazole glucocorticoid receptor agonists and antagonists.,  53  (11): [PMID:20469868] [10.1021/jm100447c]
124. Bandgar BP, Patil SA, Korbad BL, Nile SH, Khobragade CN..  (2010)  Synthesis and biological evaluation of beta-chloro vinyl chalcones as inhibitors of TNF-alpha and IL-6 with antimicrobial activity.,  45  (6): [PMID:20171758] [10.1016/j.ejmech.2010.01.050]
125. Bandgar BP, Patil SA, Korbad BL, Biradar SC, Nile SN, Khobragade CN..  (2010)  Synthesis and biological evaluation of a novel series of 2,2-bisaminomethylated aurone analogues as anti-inflammatory and antimicrobial agents.,  45  (7): [PMID:20430485] [10.1016/j.ejmech.2010.03.045]
126. Prado-Prado FJ, García-Mera X, González-Díaz H..  (2010)  Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.,  18  (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068]
127. Bandgar BP, Totre JV, Gawande SS, Khobragade CN, Warangkar SC, Kadam PD..  (2010)  Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.,  18  (16): [PMID:20638287] [10.1016/j.bmc.2010.06.046]
128. Brustolim D, Vasconcelos JF, Freitas LA, Teixeira MM, Farias MT, Ribeiro YM, Tomassini TC, Oliveira GG, Pontes-de-Carvalho LC, Ribeiro-dos-Santos R, Soares MB..  (2010)  Activity of physalin F in a collagen-induced arthritis model.,  73  (8): [PMID:20681573] [10.1021/np900691w]
129. Cole DC, Olland AM, Jacob J, Brooks J, Bursavich MG, Czerwinski R, DeClercq C, Johnson M, Joseph-McCarthy D, Ellingboe JW, Lin L, Nowak P, Presman E, Strand J, Tam A, Williams CM, Yao S, Tsao DH, Fitz LJ..  (2010)  Identification and characterization of acidic mammalian chitinase inhibitors.,  53  (16): [PMID:20666458] [10.1021/jm100533p]
130. MacDonald ML, Lamerdin J, Owens S, Keon BH, Bilter GK, Shang Z, Huang Z, Yu H, Dias J, Minami T, Michnick SW, Westwick JK..  (2006)  Identifying off-target effects and hidden phenotypes of drugs in human cells.,  (6): [PMID:16680159] [10.1038/nchembio790]
131. Krakauer T, Buckley M, Issaq HJ, Fox SD..  (2010)  Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo.,  54  (3): [PMID:20086156] [10.1128/aac.01015-09]
132. Young DW, Bender A, Hoyt J, McWhinnie E, Chirn GW, Tao CY, Tallarico JA, Labow M, Jenkins JL, Mitchison TJ, Feng Y..  (2008)  Integrating high-content screening and ligand-target prediction to identify mechanism of action.,  (1): [PMID:18066055] [10.1038/nchembio.2007.53]
133. Riether D, Harcken C, Razavi H, Kuzmich D, Gilmore T, Bentzien J, Pack EJ, Souza D, Nelson RM, Kukulka A, Fadra TN, Zuvela-Jelaska L, Pelletier J, Dinallo R, Panzenbeck M, Torcellini C, Nabozny GH, Thomson DS..  (2010)  Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimetics.,  53  (18): [PMID:20735001] [10.1021/jm100751q]
134. Eignerová B, Sedlák D, Dracínský M, Bartunek P, Kotora M..  (2010)  Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.,  53  (19): [PMID:20812681] [10.1021/jm100563h]
135. Jaroch S, Berger M, Huwe C, Krolikiewicz K, Rehwinkel H, Schäcke H, Schmees N, Skuballa W..  (2010)  Discovery of quinolines as selective glucocorticoid receptor agonists.,  20  (19): [PMID:20727743] [10.1016/j.bmcl.2010.07.125]
136. Puri N, Prakash O, Manoharlal R, Sharma M, Ghosh I, Prasad R..  (2010)  Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.,  45  (11): [PMID:20739103] [10.1016/j.ejmech.2010.07.050]
137. Bucki R, Leszczynska K, Byfield FJ, Fein DE, Won E, Cruz K, Namiot A, Kulakowska A, Namiot Z, Savage PB, Diamond SL, Janmey PA..  (2010)  Combined antibacterial and anti-inflammatory activity of a cationic disubstituted dexamethasone-spermine conjugate.,  54  (6): [PMID:20308375] [10.1128/aac.01682-09]
138. PubChem BioAssay data set, 
139. Obach RS, Lombardo F, Waters NJ..  (2008)  Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.,  36  (7): [PMID:18426954] [10.1124/dmd.108.020479]
140. Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD..  (2008)  cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.,  51  (22): [PMID:18983139] [10.1021/jm8007618]
141. Hayashi S, Nakata E, Morita A, Mizuno K, Yamamura K, Kato A, Ohashi K..  (2010)  Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships.,  18  (21): [PMID:20875743] [10.1016/j.bmc.2010.07.034]
142. Diallo H, Angell DC, Barnett HA, Biggadike K, Coe DM, Cooper TW, Craven A, Gray JR, House D, Jack TI, Keeling SP, Macdonald SJ, McLay IM, Oliver S, Taylor SJ, Uings IJ, Wellaway N..  (2011)  Discovery of a potent series of non-steroidal non α-trifluoromethyl carbinol glucocorticoid receptor agonists with reduced lipophilicity.,  21  (4): [PMID:21257309] [10.1016/j.bmcl.2010.12.121]
143. Yang MH, Wang JS, Luo JG, Wang XB, Kong LY..  (2011)  Chisopanins A-K, 11 new protolimonoids from Chisocheton paniculatus and their anti-inflammatory activities.,  19  (4): [PMID:21288727] [10.1016/j.bmc.2011.01.007]
144. Nagata N, Miyakawa M, Amano S, Furuya K, Yamamoto N, Inoguchi K..  (2011)  Design and synthesis of tricyclic tetrahydroquinolines as a new series of nonsteroidal selective androgen receptor modulators (SARMs).,  21  (6): [PMID:21349712] [10.1016/j.bmcl.2011.01.073]
145. Nhiem NX, Tai BH, Quang TH, Kiem PV, Minh CV, Nam NH, Kim JH, Im LR, Lee YM, Kim YH..  (2011)  A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.,  21  (6): [PMID:21353543] [10.1016/j.bmcl.2011.01.066]
146. Kang TH, Han NR, Kim HM, Jeong HJ..  (2011)  Blockade of IL-6 secretion pathway by the sesquiterpenoid atractylenolide III.,  74  (2): [PMID:21302967] [10.1021/np100686a]
147. Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ..  (2010)  Developing structure-activity relationships for the prediction of hepatotoxicity.,  23  (7): [PMID:20553011] [10.1021/tx1000865]
148. Ekins S, Williams AJ, Xu JJ..  (2010)  A predictive ligand-based Bayesian model for human drug-induced liver injury.,  38  (12): [PMID:20843939] [10.1124/dmd.110.035113]
149. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A..  (2010)  Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.,  23  (1): [PMID:20014752] [10.1021/tx900326k]
150. Matthews EJ, Kruhlak NL, Weaver JL, Benz RD, Contrera JF..  (2004)  Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.,  (4): [PMID:16472241] [10.2174/1570163043334794]
151. Matthews EJ, Kruhlak NL, Weaver JL, Benz RD, Contrera JF..  (2004)  Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.,  (4): [PMID:16472241] [10.2174/1570163043334794]
152. Unpublished dataset, 
153. PubChem BioAssay data set, 
154. PubChem BioAssay data set, 
155.  (2008)  Casarett and Doull's Toxicology The Basic Science of Poisons, 7th edition, 
156. Honda T, Yoshizawa H, Sundararajan C, David E, Lajoie MJ, Favaloro FG, Janosik T, Su X, Honda Y, Roebuck BD, Gribble GW..  (2011)  Tricyclic compounds containing nonenolizable cyano enones. A novel class of highly potent anti-inflammatory and cytoprotective agents.,  54  (6): [PMID:21361338] [10.1021/jm101445p]
157. Gozalbes R, Jacewicz M, Annand R, Tsaioun K, Pineda-Lucena A..  (2011)  QSAR-based permeability model for drug-like compounds.,  19  (8): [PMID:21458999] [10.1016/j.bmc.2011.03.011]
158. Fu HZ, Li CJ, Yang JZ, Shen ZF, Zhang DM..  (2011)  Potential anti-inflammatory constituents of the stems of Gordonia chrysandra.,  74  (5): [PMID:21473609] [10.1021/np200021f]
159. Xiong L, Zhu C, Li Y, Tian Y, Lin S, Yuan S, Hu J, Hou Q, Chen N, Yang Y, Shi J..  (2011)  Lignans and neolignans from Sinocalamus affinis and their absolute configurations.,  74  (5): [PMID:21469695] [10.1021/np200117y]
160. Yang BV, Weinstein DS, Doweyko LM, Gong H, Vaccaro W, Huynh T, Xiao HY, Doweyko AM, McKay L, Holloway DA, Somerville JE, Habte S, Cunningham M, McMahon M, Townsend R, Shuster D, Dodd JH, Nadler SG, Barrish JC..  (2010)  Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonists.,  53  (23): [PMID:21073190] [10.1021/jm100957a]
161. Tale RH, Rodge AH, Hatnapure GD, Keche AP..  (2011)  The novel 3,4-dihydropyrimidin-2(1H)-one urea derivatives of N-aryl urea: synthesis, anti-inflammatory, antibacterial and antifungal activity evaluation.,  21  (15): [PMID:21737269] [10.1016/j.bmcl.2011.03.062]
162. Chou BH, Yang LM, Chang SF, Hsu FL, Wang LH, Lin WK, Liu PC, Lin SJ..  (2011)  Transformation of isosteviol lactam by fungi and the suppressive effects of its transformed products on LPS-induced iNOS expression in macrophages.,  74  (6): [PMID:21598928] [10.1021/np100915q]
163. Zhang L, Feng L, Jia Q, Xu J, Wang R, Wang Z, Wu Y, Li Y..  (2011)  Effects of β-glucosidase hydrolyzed products of harpagide and harpagoside on cyclooxygenase-2 (COX-2) in vitro.,  19  (16): [PMID:21775152] [10.1016/j.bmc.2011.06.069]
164. dos Santos JL, Lanaro C, Lima LM, Gambero S, Franco-Penteado CF, Alexandre-Moreira MS, Wade M, Yerigenahally S, Kutlar A, Meiler SE, Costa FF, Chung M..  (2011)  Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms.,  54  (16): [PMID:21766854] [10.1021/jm200531f]
165. de Oliveira CM, Nonato FR, de Lima FO, Couto RD, David JP, David JM, Soares MB, Villarreal CF..  (2011)  Antinociceptive properties of bergenin.,  74  (10): [PMID:21939182] [10.1021/np200232s]
166. Genovese S, Curini M, Gresele P, Corazzi T, Epifano F..  (2011)  Inhibition of COX-1 activity and COX-2 expression by 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its semi-synthetic derivatives.,  21  (19): [PMID:21843935] [10.1016/j.bmcl.2011.07.040]
167. PubChem BioAssay data set, 
168. PubChem BioAssay data set, 
169. Polli JW, Wring SA, Humphreys JE, Huang L, Morgan JB, Webster LO, Serabjit-Singh CS..  (2001)  Rational use of in vitro P-glycoprotein assays in drug discovery.,  299  (2): [PMID:11602674]
170. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, 
171. Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W..  (2011)  FDA-approved drug labeling for the study of drug-induced liver injury.,  16  (15-16): [PMID:21624500] [10.1016/j.drudis.2011.05.007]
172. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W..  (2011)  Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).,  (12): [PMID:22194678] [10.1371/journal.pcbi.1002310]
173. Nagata N, Miyakawa M, Amano S, Furuya K, Yamamoto N, Nejishima H, Inoguchi K..  (2011)  Tetrahydroquinolines as a novel series of nonsteroidal selective androgen receptor modulators: structural requirements for better physicochemical and biological properties.,  21  (21): [PMID:21944856] [10.1016/j.bmcl.2011.08.118]
174. Weinstein DS, Gong H, Doweyko AM, Cunningham M, Habte S, Wang JH, Holloway DA, Burke C, Gao L, Guarino V, Carman J, Somerville JE, Shuster D, Salter-Cid L, Dodd JH, Nadler SG, Barrish JC..  (2011)  Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826).,  54  (20): [PMID:21899328] [10.1021/jm200879j]
175. Betageri R, Gilmore T, Kuzmich D, Kirrane TM, Bentzien J, Wiedenmayer D, Bekkali Y, Regan J, Berry A, Latli B, Kukulka AJ, Fadra TN, Nelson RM, Goldrick S, Zuvela-Jelaska L, Souza D, Pelletier J, Dinallo R, Panzenbeck M, Torcellini C, Lee H, Pack E, Harcken C, Nabozny G, Thomson DS..  (2011)  Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores.,  21  (22): [PMID:21963986] [10.1016/j.bmcl.2011.09.018]
176. Crosignani S, Prêtre A, Jorand-Lebrun C, Fraboulet G, Seenisamy J, Augustine JK, Missotten M, Humbert Y, Cleva C, Abla N, Daff H, Schott O, Schneider M, Burgat-Charvillon F, Rivron D, Hamernig I, Arrighi JF, Gaudet M, Zimmerli SC, Juillard P, Johnson Z..  (2011)  Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.,  54  (20): [PMID:21916510] [10.1021/jm200866y]
177. Giner E, El Alami M, Máñez S, Recio MC, Ríos JL, Giner RM..  (2011)  Phenolic substances from Phagnalon rupestre protect against 2,4,6-trinitrochlorobenzene-induced contact hypersensitivity.,  74  (5): [PMID:21469692] [10.1021/np100934u]
178. PubChem BioAssay data set, 
179. Keche AP, Hatnapure GD, Tale RH, Rodge AH, Birajdar SS, Kamble VM..  (2012)  A novel pyrimidine derivatives with aryl urea, thiourea and sulfonamide moieties: synthesis, anti-inflammatory and antimicrobial evaluation.,  22  (10): [PMID:22520258] [10.1016/j.bmcl.2012.03.092]
180. Foot JS, Deodhar M, Turner CI, Yin P, van Dam EM, Silva DG, Olivieri A, Holt A, McDonald IA..  (2012)  The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).,  22  (12): [PMID:22595173] [10.1016/j.bmcl.2012.04.111]
181. Zhang F, Wang JS, Gu YC, Kong LY..  (2012)  Cytotoxic and anti-inflammatory triterpenoids from Toona ciliata.,  75  (4): [PMID:22537362] [10.1021/np200579b]
182. William AD, Lee AC, Poulsen A, Goh KC, Madan B, Hart S, Tan E, Wang H, Nagaraj H, Chen D, Lee CP, Sun ET, Jayaraman R, Pasha MK, Ethirajulu K, Wood JM, Dymock BW..  (2012)  Discovery of the macrocycle (9E)-15-(2-(pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14(26),15,17,20,22-nonaene (SB1578), a potent inhibitor of janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) for the treatment of rheumatoid arthritis.,  55  (6): [PMID:22339472] [10.1021/jm201454n]
183. Zhang M, Iinuma M, Wang JS, Oyama M, Ito T, Kong LY..  (2012)  Terpenoids from Chloranthus serratus and their anti-inflammatory activities.,  75  (4): [PMID:22372956] [10.1021/np200968p]
184. Liu JH, Zhao N, Zhang GJ, Yu SS, Wu LJ, Qu J, Ma SG, Chen XG, Zhang TQ, Bai J, Chen H, Fang ZF, Zhao F, Tang WB..  (2012)  Bioactive quassinoids from the seeds of Brucea javanica.,  75  (4): [PMID:22506620] [10.1021/np200920c]
185. Crosignani S, Jorand-Lebrun C, Page P, Campbell G, Colovray V, Missotten M, Humbert Y, Cleva C, Arrighi JF, Gaudet M, Johnson Z, Ferro P, Chollet A..  (2011)  Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists.,  (8): [PMID:24900359] [10.1021/ml2001196]
186. Kim HJ, Lee SH, Koh JS, Lee SH..  (2012)  Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities.,  22  (9): [PMID:22497764] [10.1016/j.bmcl.2012.03.070]
187. Ellard K, Sunose M, Bell K, Ramsden N, Bergamini G, Neubauer G..  (2012)  Discovery of novel PI3Kγ/δ inhibitors as potential agents for inflammation.,  22  (14): [PMID:22738635] [10.1016/j.bmcl.2012.05.121]
188. Sakatis MZ, Reese MJ, Harrell AW, Taylor MA, Baines IA, Chen L, Bloomer JC, Yang EY, Ellens HM, Ambroso JL, Lovatt CA, Ayrton AD, Clarke SE..  (2012)  Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.,  25  (10): [PMID:22931300] [10.1021/tx300075j]
189. De Simone R, Bruno I, Riccio R, Stadler K, Bauer J, Schaible AM, Laufer S, Werz O..  (2012)  Identification of new γ-hydroxybutenolides that preferentially inhibit the activity of mPGES-1.,  20  (16): [PMID:22795900] [10.1016/j.bmc.2012.06.032]
190. Romiti N, Tramonti G, Chieli E..  (2002)  Influence of different chemicals on MDR-1 P-glycoprotein expression and activity in the HK-2 proximal tubular cell line.,  183  (1): [PMID:12387747] [10.1006/taap.2002.9461]
191. Schwab D, Fischer H, Tabatabaei A, Poli S, Huwyler J..  (2003)  Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.,  46  (9): [PMID:12699389] [10.1021/jm021012t]
192. Geick A, Eichelbaum M, Burk O..  (2001)  Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin.,  276  (1): [PMID:11297522] [10.1074/jbc.m010173200]
193. Yates CR, Chang C, Kearbey JD, Yasuda K, Schuetz EG, Miller DD, Dalton JT, Swaan PW..  (2003)  Structural determinants of P-glycoprotein-mediated transport of glucocorticoids.,  20  (1): [PMID:14661924] [10.1023/b:pham.0000003377.39548.f6]
194. Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P..  (1995)  Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.,  96  (1): [PMID:7560060] [10.1172/jci118214]
195. Bossuyt X, Müller M, Hagenbuch B, Meier PJ..  (1996)  Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.,  276  (1): [PMID:8786566]
196. Fardel O, Payen L, Courtois A, Vernhet L, Lecureur V..  (2001)  Regulation of biliary drug efflux pump expression by hormones and xenobiotics.,  167  (1): [PMID:11557128] [10.1016/s0300-483x(01)00456-5]
197. Schrenk D, Baus PR, Ermel N, Klein C, Vorderstemann B, Kauffmann HM..  (2001)  Up-regulation of transporters of the MRP family by drugs and toxins.,  120  (1): [PMID:11323161] [10.1016/s0378-4274(01)00306-x]
198. Kullak-Ublick GA, Fisch T, Oswald M, Hagenbuch B, Meier PJ, Beuers U, Paumgartner G..  (1998)  Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain.,  424  (1): [PMID:9539145] [10.1016/s0014-5793(98)00168-9]
199. Demeule M, Jodoin J, Beaulieu E, Brossard M, Béliveau R..  (1999)  Dexamethasone modulation of multidrug transporters in normal tissues.,  442  (1): [PMID:9929003] [10.1016/s0014-5793(98)01663-9]
200. Fardel O, Lecureur V, Guillouzo A..  (1993)  Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes.,  327  (1): [PMID:8101494] [10.1016/0014-5793(93)80167-s]
201. Schuetz JD, Silverman JA, Thottassery JV, Furuya KN, Schuetz EG..  (1995)  Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids.,  (1): [PMID:8845310]
202. Polli JW, Wring SA, Humphreys JE, Huang L, Morgan JB, Webster LO, Serabjit-Singh CS..  (2001)  Rational use of in vitro P-glycoprotein assays in drug discovery.,  299  (2): [PMID:11602674]
203. Adachi Y, Suzuki H, Sugiyama Y..  (2001)  Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein.,  18  (1): [PMID:11785684] [10.1023/a:1013358126640]
204. Masuda S, Ibaramoto K, Takeuchi A, Saito H, Hashimoto Y, Inui KI..  (1999)  Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney.,  55  (1): [PMID:10101033]
205. Guo GL, Choudhuri S, Klaassen CD..  (2002)  Induction profile of rat organic anion transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factor pathways.,  300  (1): [PMID:11752118] [10.1124/jpet.300.1.206]
206. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
207. de Lima FO, Nonato FR, Couto RD, Barbosa Filho JM, Nunes XP, Ribeiro dos Santos R, Soares MB, Villarreal CF..  (2011)  Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin.,  74  (4): [PMID:21417376] [10.1021/np100621c]
208. Baumgartner L, Sosa S, Atanasov AG, Bodensieck A, Fakhrudin N, Bauer J, Favero GD, Ponti C, Heiss EH, Schwaiger S, Ladurner A, Widowitz U, Loggia RD, Rollinger JM, Werz O, Bauer R, Dirsch VM, Tubaro A, Stuppner H..  (2011)  Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and pro-inflammatory mediators in vitro.,  74  (8): [PMID:21800856] [10.1021/np200343t]
209. Hatnapure GD, Keche AP, Rodge AH, Birajdar SS, Tale RH, Kamble VM..  (2012)  Synthesis and biological evaluation of novel piperazine derivatives of flavone as potent anti-inflammatory and antimicrobial agent.,  22  (20): [PMID:22981334] [10.1016/j.bmcl.2012.08.071]
210. Lansdell TA, O'Reilly S, Woolliscroft T, Azevedo LM, Kahlon DK, Hovde S, McCormick JJ, Henry RW, Cornicelli JA, Tepe JJ..  (2012)  Attenuation of collagen-induced arthritis by orally available imidazoline-based NF-κB inhibitors.,  22  (14): [PMID:22682057] [10.1016/j.bmcl.2012.05.056]
211. Keche AP, Hatnapure GD, Tale RH, Rodge AH, Kamble VM..  (2012)  Synthesis, anti-inflammatory and antimicrobial evaluation of novel 1-acetyl-3,5-diaryl-4,5-dihydro (1H) pyrazole derivatives bearing urea, thiourea and sulfonamide moieties.,  22  (21): [PMID:23026000] [10.1016/j.bmcl.2012.08.118]
212. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P..  (2012)  Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.,  55  (10): [PMID:22541068] [10.1021/jm300212s]
213. Cushing TD, Metz DP, Whittington DA, McGee LR..  (2012)  PI3Kδ and PI3Kγ as targets for autoimmune and inflammatory diseases.,  55  (20): [PMID:22924688] [10.1021/jm300847w]
214. Bandgar B, Hote B, Gangwal R, Sangamwar A.  (2012)  Synthesis, biological evaluation, and pharmacokinetic profiling of benzophenone derivatives as tumor necrosis factor-alpha and interleukin-6 inhibitors,  21  (10): [10.1007/s00044-011-9856-1]
215. Bandgar BP, Hote BS, Jalde SS, Gacche RN.  (2012)  Synthesis and biological evaluation of novel curcumin analogues as anti-inflammatory, anti-cancer and anti-oxidant agents,  21  (10): [10.1007/s00044-011-9834-7]
216. Akamatsu M..  (2011)  Importance of physicochemical properties for the design of new pesticides.,  59  (7): [PMID:20879794] [10.1021/jf102525e]
217. Tale RH, Rodge AH, Hatnapure GD, Keche AP, Patil KM, Pawar RP.  (2012)  The synthesis, anti-inflammatory and antimicrobial activity evaluation of novel thioanalogs of 3,4-dihydrothiopyrimidin-2(1H)-one derivatives of N-aryl urea,  21  (12): [10.1007/s00044-011-9943-3]
218. Mahjoub MA, Ammar S, Edziri H, Mighri N, Bouraoui A, Mighri Z.  (2010)  Anti-inflammatory and antioxidant activities of some extracts and pure natural products isolated from Rhus tripartitum (Ucria),  19  (3): [10.1007/s00044-009-9190-z]
219. Tale RH, Rodge AH, Hatnapure GD, Keche AP, Patil KM, Pawar RP.  (2013)  The synthesis, anti-inflammatory, and anti-microbial activity evaluation of new series of 4-(3-arylureido)phenyl-1,4-dihydropyridine urea derivatives,  22  (3): [10.1007/s00044-012-0109-8]
220. Keche AP, Hatnapure GD, Tale RH, Rodge AH, Birajdar SS, Kamble VM.  (2013)  Synthesis, anti-inflammatory and antimicrobial evaluation of novel N1-(quinolin-4yl)ethane-1,2-diamine phenyl urea derivatives,  22  (3): [10.1007/s00044-012-0144-5]
221. Marzouk B, Mahjoub MA, Bouraoui A, Fenina N, Aouni M, Marzouk Z.  (2013)  Anti-inflammatory and analgesic activities of a new cucurbitacin isolated from Citrullus colocynthis seeds,  22  (8): [10.1007/s00044-012-0406-2]
222. Zhou Z, Zhang H.  (2013)  Phenolic and iridoid glycosides from the rhizomes of Cyperus rotundus L.,  22  (10): [10.1007/s00044-013-0504-9]
223. Wittwer MB, Zur AA, Khuri N, Kido Y, Kosaka A, Zhang X, Morrissey KM, Sali A, Huang Y, Giacomini KM..  (2013)  Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.,  56  (3): [PMID:23241029] [10.1021/jm301302s]
224. Tomašković L, Komac M, Makaruha Stegić O, Munić V, Ralić J, Stanić B, Banjanac M, Marković S, Hrvačić B, Čipčić Paljetak H, Padovan J, Glojnarić I, Eraković Haber V, Mesić M, Merćep M..  (2013)  Macrolactonolides: a novel class of anti-inflammatory compounds.,  21  (1): [PMID:23199485] [10.1016/j.bmc.2012.10.036]
225. Batie S, Lee JH, Jama RA, Browder DO, Montano LA, Huynh CC, Marcus LM, Tsosie DG, Mohammed Z, Trang V, Marshall PA, Jurutka PW, Wagner CE..  (2013)  Synthesis and biological evaluation of halogenated curcumin analogs as potential nuclear receptor selective agonists.,  21  (3): [PMID:23276449] [10.1016/j.bmc.2012.11.033]
226. Michelini FM, Zorrilla P, Robello C, Alché LE..  (2013)  Immunomodulatory activity of an anti-HSV-1 synthetic stigmastane analog.,  21  (2): [PMID:23219855] [10.1016/j.bmc.2012.10.054]
227. You R, Long W, Lai Z, Sha L, Wu K, Yu X, Lai Y, Ji H, Huang Z, Zhang Y..  (2013)  Discovery of a potential anti-inflammatory agent: 3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile.,  56  (5): [PMID:23373965] [10.1021/jm301652t]
228. Wang C, Li CJ, Yang JZ, Ma J, Chen XG, Hou Q, Zhang DM..  (2013)  Anti-inflammatory sesquiterpene derivatives from the leaves of Tripterygium wilfordii.,  76  (1): [PMID:23268606] [10.1021/np300759u]
229. Akama T, Virtucio C, Dong C, Kimura R, Zhang YK, Nieman JA, Sharma R, Lu X, Sales M, Singh R, Wu A, Fan XQ, Liu L, Plattner JJ, Jarnagin K, Freund YR..  (2013)  Structure-activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent.,  23  (6): [PMID:23411072] [10.1016/j.bmcl.2013.01.072]
230. Giner E, Recio MC, Ríos JL, Giner RM..  (2013)  Oleuropein protects against dextran sodium sulfate-induced chronic colitis in mice.,  76  (6): [PMID:23758110] [10.1021/np400175b]
231. Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M..  (2013)  Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,  21  (10): [PMID:23582449] [10.1016/j.bmc.2013.03.016]
232. Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B..  (2013)  Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,  23  (6): [PMID:23403082] [10.1016/j.bmcl.2013.01.025]
233. Cappelli A, Manini M, Valenti S, Castriconi F, Giuliani G, Anzini M, Brogi S, Butini S, Gemma S, Campiani G, Giorgi G, Mennuni L, Lanza M, Giordani A, Caselli G, Letari O, Makovec F..  (2013)  Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.,  63  [PMID:23466604] [10.1016/j.ejmech.2013.01.044]
234. Yuvaraj S, Mendon M, Almeida A, Dhiman M, Girish M.  (2013)  Synthesis of novel bioactive pyrazolothiazoles,  [10.1007/s00044-013-0825-8]
235. Gilmore JL, Sheppeck JE, Wang J, Dhar TG, Cavallaro C, Doweyko AM, Mckay L, Cunningham MD, Habte SF, Nadler SG, Dodd JH, Somerville JE, Barrish JC..  (2013)  Synthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists.,  23  (19): [PMID:23916594] [10.1016/j.bmcl.2013.06.085]
236. Xiao HY, Wu DR, Sheppeck JE, Habte SF, Cunningham MD, Somerville JE, Barrish JC, Nadler SG, Dhar TG..  (2013)  Heterocyclic glucocorticoid receptor modulators with a 2,2-dimethyl-3-phenyl-N-(thiazol or thiadiazol-2-yl)propanamide core.,  23  (20): [PMID:24011644] [10.1016/j.bmcl.2013.08.049]
237. Sheppeck JE, Gilmore JL, Xiao HY, Dhar TG, Nirschl D, Doweyko AM, Sack JS, Corbett MJ, Malley MF, Gougoutas JZ, Mckay L, Cunningham MD, Habte SF, Dodd JH, Nadler SG, Somerville JE, Barrish JC..  (2013)  Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists.,  23  (19): [PMID:23953070] [10.1016/j.bmcl.2013.06.089]
238. Chung HS, Kim Y, Oh SJ, Kim H, Choi SI, Zhang Y, Jeong JH, Bae H..  (2013)  A synthetic compound, 4-acetyl-3-methyl-6-(3,4,5-trimethoxyphenyl)pyrano[3,4-c]pyran-1,8-dione, ameliorates ovalbumin-induced asthma.,  21  (21): [PMID:24054491] [10.1016/j.bmc.2013.08.045]
239. Unpublished dataset, 
240. Unpublished dataset, 
241. Unpublished dataset, 
242. Unpublished dataset, 
243. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP..  (2013)  Structure-based identification of OATP1B1/3 inhibitors.,  83  (6): [PMID:23571415] [10.1124/mol.112.084152]
244. Kuzmich D, Bentzien J, Betageri R, DiSalvo D, Fadra-Khan T, Harcken C, Kukulka A, Nabozny G, Nelson R, Pack E, Souza D, Thomson D..  (2013)  Function-regulating pharmacophores in a sulfonamide class of glucocorticoid receptor agonists.,  23  (24): [PMID:24215891] [10.1016/j.bmcl.2013.10.052]
245. Carson MW, Luz JG, Suen C, Montrose C, Zink R, Ruan X, Cheng C, Cole H, Adrian MD, Kohlman DT, Mabry T, Snyder N, Condon B, Maletic M, Clawson D, Pustilnik A, Coghlan MJ..  (2014)  Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design.,  57  (3): [PMID:24446728] [10.1021/jm401616g]
246. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R..  (2004)  [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs].,  28  (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2]
247. PubChem BioAssay data set, 
248. Razavi H, Riether D, Harcken C, Bentzien J, Dinallo RM, Souza D, Nelson RM, Kukulka A, Fadra-Khan TN, Pack EJ, Zuvela-Jelaska L, Pelletier J, Panzenbeck M, Torcellini CA, Proudfoot JR, Nabozny GH, Thomson DS..  (2014)  Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore.,  24  (8): [PMID:24656565] [10.1016/j.bmcl.2014.03.005]
249. Kaila N, Follows B, Leung L, Thomason J, Huang A, Moretto A, Janz K, Lowe M, Mansour TS, Hubeau C, Page K, Morgan P, Fish S, Xu X, Williams C, Saiah E..  (2014)  Discovery of isoquinolinone indole acetic acids as antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases.,  57  (4): [PMID:24512187] [10.1021/jm401509e]
250. Fryer RI, Boris A, Earley JV, Reeder E..  (1977)  2-(2-Aminoethylamino)-1,2-diphenylethanol derivatives, a new class of topical antiinflammatory agents.,  20  (10): [PMID:71349] [10.1021/jm00220a008]
251. Martino T, Magalhães FC, Justo GA, Coelho MG, Netto CD, Costa PR, Sabino KC..  (2014)  The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.,  22  (12): [PMID:24794748] [10.1016/j.bmc.2014.04.025]
252. Sau S, Banerjee R..  (2014)  Cationic lipid-conjugated dexamethasone as a selective antitumor agent.,  83  [PMID:24992071] [10.1016/j.ejmech.2014.06.051]
253. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds,  [10.6019/CHEMBL3301361]
254. Gege C, Schlüter T, Hoffmann T..  (2014)  Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.,  24  (22): [PMID:25305688] [10.1016/j.bmcl.2014.09.053]
255. Chaudhary D, Robinson S, Romero DL..  (2015)  Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders.,  58  (1): [PMID:25479567] [10.1021/jm5016044]
256. Cantley AM, Welsch M, Ambesi-Impiombato A, Sanchez-Martin M, Kim MY, Bauer A, Ferrando A, Stockwell BR..  (2014)  Small Molecule that Reverses Dexamethasone Resistance in T-cell Acute Lymphoblastic Leukemia (T-ALL).,  (7): [PMID:25050160] [10.1021/ml500044g]
257. Tomoo T, Nakatsuka T, Katayama T, Hayashi Y, Fujieda Y, Terakawa M, Nagahira K..  (2014)  Design, synthesis, and biological evaluation of 3-(1-Aryl-1H-indol-5-yl)propanoic acids as new indole-based cytosolic phospholipase A2α inhibitors.,  57  (17): [PMID:25102418] [10.1021/jm500494y]
258. Lima Mda S, Evangelista AF, Santos GG, Ribeiro IM, Tomassini TC, Pereira Soares MB, Villarreal CF..  (2014)  Antinociceptive properties of physalins from Physalis angulata.,  77  (11): [PMID:25396337] [10.1021/np5003093]
259. Nhiem NX, Hien NT, Tai BH, Anh Hle T, Hang DT, Quang TH, Kiem PV, Minh CV, Ko W, Lee S, Oh H, Kim SH, Kim YH..  (2015)  New ent-kauranes from the fruits of Annona glabra and their inhibitory nitric oxide production in LPS-stimulated RAW264.7 macrophages.,  25  (2): [PMID:25499882] [10.1016/j.bmcl.2014.11.059]
260. Bhandari P, Patel NK, Gangwal RP, Sangamwar AT, Bhutani KK..  (2014)  Oleanolic acid analogs as NO, TNF-α and IL-1β inhibitors: synthesis, biological evaluation and docking studies.,  24  (17): [PMID:25113933] [10.1016/j.bmcl.2014.07.056]
261. Bukhari SN, Lauro G, Jantan I, Bifulco G, Amjad MW..  (2014)  Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.,  22  (15): [PMID:24938495] [10.1016/j.bmc.2014.05.052]
262. Wu ZY, Zhang YB, Zhu KK, Luo C, Zhang JX, Cheng CR, Feng RH, Yang WZ, Zeng F, Wang Y, Xu PP, Guo JL, Liu X, Guan SH, Guo DA..  (2014)  Anti-inflammatory diterpenoids from the root bark of Acanthopanax gracilistylus.,  77  (11): [PMID:25338180] [10.1021/np500125x]
263. Harcken C, Riether D, Liu P, Razavi H, Patel U, Lee T, Bosanac T, Ward Y, Ralph M, Chen Z, Souza D, Nelson RM, Kukulka A, Fadra-Khan TN, Zuvela-Jelaska L, Patel M, Thomson DS, Nabozny GH..  (2014)  Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.,  (12): [PMID:25516791] [10.1021/ml500387y]
264. Ye N, Ding Y, Wild C, Shen Q, Zhou J..  (2014)  Small molecule inhibitors targeting activator protein 1 (AP-1).,  57  (16): [PMID:24831826] [10.1021/jm5004733]
265. Gong H, Yang M, Xiao Z, Doweyko AM, Cunningham M, Wang J, Habte S, Holloway D, Burke C, Shuster D, Gao L, Carman J, Somerville JE, Nadler SG, Salter-Cid L, Barrish JC, Weinstein DS..  (2014)  Discovery of acylurea isosteres of 2-acylaminothiadiazole in the azaxanthene series of glucocorticoid receptor agonists.,  24  (15): [PMID:24980053] [10.1016/j.bmcl.2014.06.010]
266. Bhandari P, Patel NK, Bhutani KK..  (2014)  Synthesis of new heterocyclic lupeol derivatives as nitric oxide and pro-inflammatory cytokine inhibitors.,  24  (15): [PMID:24909081] [10.1016/j.bmcl.2014.05.032]
267. Patel NK, Bairwa K, Gangwal R, Jaiswal G, Jachak SM, Sangamwar AT, Bhutani KK..  (2015)  2'-Hydroxy flavanone derivatives as an inhibitors of pro-inflammatory mediators: Experimental and molecular docking studies.,  25  (9): [PMID:25824662] [10.1016/j.bmcl.2015.03.025]
268. Esteve C, González J, Gual S, Vidal L, Alzina S, Sentellas S, Jover I, Horrillo R, De Alba J, Miralpeix M, Tarrasón G, Vidal B..  (2015)  Discovery of 7-azaindole derivatives as potent Orai inhibitors showing efficacy in a preclinical model of asthma.,  25  (6): [PMID:25690784] [10.1016/j.bmcl.2015.01.063]
269. Xue ST, Guo HF, Liu MJ, Jin J, Ju DH, Liu ZY, Li ZR..  (2015)  Synthesis of a novel class of substituted benzothiophene or benzofuran derivatives as BMP-2 up-regulators and evaluation of the BMP-2-up-regulating effects in vitro and the effects on glucocorticoid-induced osteoporosis in rats.,  96  [PMID:25874339] [10.1016/j.ejmech.2015.04.016]
270. Chantigny YA, Murray JC, Kleinman EF, Robinson RP, Plotkin MA, Reese MR, Buckbinder L, McNiff PA, Millham ML, Schaefer JF, Abramov YA, Bordner J..  (2015)  2-Aryl-3-methyloctahydrophenanthrene-2,3,7-triols as potent dissociated glucocorticoid receptor agonists.,  58  (6): [PMID:25706100] [10.1021/jm501601b]
271. Silva RL, Lopes AH, França RO, Vieira SM, Silva EC, Amorim RC, Cunha FQ, Pohlit AM, Cunha TM..  (2015)  The quassinoid isobrucein B reduces inflammatory hyperalgesia and cytokine production by post-transcriptional modulation.,  78  (2): [PMID:25667960] [10.1021/np500796f]
272. Lau AJ, Yang G, Rajaraman G, Baucom CC, Chang TK..  (2012)  Species-dependent and receptor-selective action of bilobalide on the function of constitutive androstane receptor and pregnane X receptor.,  40  (1): [PMID:22019630] [10.1124/dmd.111.042879]
273. Farrell TL, Poquet L, Dew TP, Barber S, Williamson G..  (2012)  Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.,  40  (2): [PMID:22096083] [10.1124/dmd.111.041665]
274. Ren S, Zeng J, Mei Y, Zhang JZ, Yan SF, Fei J, Chen L..  (2013)  Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.,  41  (1): [PMID:23033255] [10.1124/dmd.112.048264]
275. Dawson S, Stahl S, Paul N, Barber J, Kenna JG..  (2012)  In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.,  40  (1): [PMID:21965623] [10.1124/dmd.111.040758]
276. Shukla SJ, Sakamuru S, Huang R, Moeller TA, Shinn P, Vanleer D, Auld DS, Austin CP, Xia M..  (2011)  Identification of clinically used drugs that activate pregnane X receptors.,  39  (1): [PMID:20966043] [10.1124/dmd.110.035105]
277. PubChem BioAssay data set, 
278. Eda M, Kuroda T, Kaneko S, Aoki Y, Yamashita M, Okumura C, Ikeda Y, Ohbora T, Sakaue M, Koyama N, Aritomo K..  (2015)  Synthesis and Biological Evaluation of Cyclopentaquinoline Derivatives as Nonsteroidal Glucocorticoid Receptor Antagonists.,  58  (12): [PMID:25978072] [10.1021/jm501758q]
279. McElroy WT, Tan Z, Ho G, Paliwal S, Li G, Seganish WM, Tulshian D, Tata J, Fischmann TO, Sondey C, Bian H, Bober L, Jackson J, Garlisi CG, Devito K, Fossetta J, Lundell D, Niu X..  (2015)  Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation.,  (6): [PMID:26101573] [10.1021/acsmedchemlett.5b00106]
280. Xu LL, Zhu JF, Xu XL, Zhu J, Li L, Xi MY, Jiang ZY, Zhang MY, Liu F, Lu MC, Bao QC, Li Q, Zhang C, Wei JL, Zhang XJ, Zhang LS, You QD, Sun HP..  (2015)  Discovery and Modification of in Vivo Active Nrf2 Activators with 1,2,4-Oxadiazole Core: Hits Identification and Structure-Activity Relationship Study.,  58  (14): [PMID:26111355] [10.1021/acs.jmedchem.5b00170]
281. Lai Y, Liu T, Sa R, Wei X, Xue Y, Wu Z, Luo Z, Xiang M, Zhang Y, Yao G..  (2015)  Neolignans with a Rare 2-Oxaspiro[4.5]deca-6,9-dien-8-one Motif from the Stem Bark of Cinnamomum subavenium.,  78  (7): [PMID:26087384] [10.1021/np5010533]
282. Shi YS, Liu YB, Ma SG, Li Y, Qu J, Li L, Yuan SP, Hou Q, Li YH, Jiang JD, Yu SS..  (2015)  Bioactive Sesquiterpenes and Lignans from the Fruits of Xanthium sibiricum.,  78  (7): [PMID:26110443] [10.1021/np500951s]
283. de Meneses Santos R, Barros PR, Bortoluzzi JH, Meneghetti MR, da Silva YK, da Silva AE, da Silva Santos M, Alexandre-Moreira MS..  (2015)  Synthesis and evaluation of the anti-nociceptive and anti-inflammatory activity of 4-aminoquinoline derivatives.,  23  (15): [PMID:26116178] [10.1016/j.bmc.2015.06.029]
284. Jiang ZY, Xu LL, Lu MC, Chen ZY, Yuan ZW, Xu XL, Guo XK, Zhang XJ, Sun HP, You QD..  (2015)  Structure-Activity and Structure-Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1-Nrf2 Protein-Protein Interaction Inhibitor.,  58  (16): [PMID:26258437] [10.1021/acs.jmedchem.5b00185]
285. Lu Y, Xue Y, Liu J, Yao G, Li D, Sun B, Zhang J, Liu Y, Qi C, Xiang M, Luo Z, Du G, Zhang Y..  (2015)  (±)-Acortatarinowins A-F, Norlignan, Neolignan, and Lignan Enantiomers from Acorus tatarinowii.,  78  (9): [PMID:26305406] [10.1021/acs.jnatprod.5b00328]
286. Yu H, Mei S, Zhao L, Zhao M, Wang Y, Zhu H, Wang Y, Wu J, Cui C, Xu W, Peng S.  (2015)  RGD-peptides modifying dexamethasone: to enhance the anti-inflammatory efficacy and limit the risk of osteoporosis,  (7): [10.1039/C5MD00215J]
287. Waszkielewicz AM, Gunia-Krzyżak A, Powroźnik B, Słoczyńska K, Pękala E, Walczak M, Bednarski M, Żesławska E, Nitek W, Marona H..  (2016)  Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.,  24  (8): [PMID:26988801] [10.1016/j.bmc.2016.03.006]
288. Laavola M, Haavikko R, Hämäläinen M, Leppänen T, Nieminen R, Alakurtti S, Moreira VM, Yli-Kauhaluoma J, Moilanen E..  (2016)  Betulin Derivatives Effectively Suppress Inflammation in Vitro and in Vivo.,  79  (2): [PMID:26915998] [10.1021/acs.jnatprod.5b00709]
289. Su YD, Cheng CH, Wen ZH, Wu YC, Sung PJ..  (2016)  New anti-inflammatory sterols from a gorgonian Pinnigorgia sp.,  26  (13): [PMID:27217003] [10.1016/j.bmcl.2016.05.015]
290. Riça IG, Netto CD, Rennó MN, Abreu PA, Costa PR, da Silva AJ, Cavalcante MC..  (2016)  Anti-inflammatory properties of pterocarpanquinone LQB-118 in mice.,  24  (18): [PMID:27492193] [10.1016/j.bmc.2016.07.046]
291. WHO Anatomical Therapeutic Chemical Classification, 
292. British National Formulary (72nd edition), 
293. Correa LB, Pádua TA, Seito LN, Costa TE, Silva MA, Candéa AL, Rosas EC, Henriques MG..  (2016)  Anti-inflammatory Effect of Methyl Gallate on Experimental Arthritis: Inhibition of Neutrophil Recruitment, Production of Inflammatory Mediators, and Activation of Macrophages.,  79  (6): [PMID:27227459] [10.1021/acs.jnatprod.5b01115]
294. Rech JC, Bhattacharya A, Branstetter BJ, Love CJ, Leenaerts JE, Cooymans LP, Eckert WA, Ao H, Wang Q, Chaplan SR, Wickenden AD, Lebsack AD, Breitenbucher JG..  (2016)  The discovery and preclinical characterization of 6-chloro-N-(2-(4,4-difluoropiperidin-1-yl)-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethyl)quinoline-5-carboxamide based P2X7 antagonists.,  26  (19): [PMID:27595421] [10.1016/j.bmcl.2016.08.029]
295. Hemmerling M, Edman K, Lepistö M, Eriksson A, Ivanova S, Dahmén J, Rehwinkel H, Berger M, Hendrickx R, Dearman M, Jensen TJ, Wissler L, Hansson T..  (2016)  Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators.,  26  (23): [PMID:27810243] [10.1016/j.bmcl.2016.10.052]
296. Zhan G, Zhou J, Liu T, Zheng G, Aisa HA, Yao G..  (2016)  Flavans with potential anti-inflammatory activities from Zephyranthes candida.,  26  (24): [PMID:27825545] [10.1016/j.bmcl.2016.10.081]
297. Jin Z, Lin H, Srinivasan S, Nwachukwu JC, Bruno N, Griffin PR, Nettles KW, Kamenecka TM..  (2017)  Synthesis of novel steroidal agonists, partial agonists, and antagonists for the glucocorticoid receptor.,  27  (2): [PMID:27919657] [10.1016/j.bmcl.2016.11.007]
298. Gunia-Krzyżak A, Żelaszczyk D, Rapacz A, Żesławska E, Waszkielewicz AM, Pańczyk K, Słoczyńska K, Pękala E, Nitek W, Filipek B, Marona H..  (2017)  Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH3 or 2-CH3.,  25  (2): [PMID:27876250] [10.1016/j.bmc.2016.11.014]
299. Pikuła M, Smużyńska M, Krzystyniak A, Zieliński M, Langa P, Deptuła M, Schumacher A, Łata J, Cichorek M, Grubb A, Trzonkowski P, Kasprzykowski F, Rodziewicz-Motowidło S..  (2017)  Cystatin C peptidomimetic derivative with antimicrobial properties as a potential compound against wound infections.,  25  (4): [PMID:28110818] [10.1016/j.bmc.2017.01.004]
300.  (2009)  Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity, 
301. Open TG-GATES,  [10.6019/CHEMBL3885861]
302. DrugMatrix,  [10.6019/CHEMBL3885881]
303. Chinthakindi PK, Singh J, Gupta S, Nargotra A, Mahajan P, Kaul A, Ahmed Z, Koul S, Sangwan PL..  (2017)  Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships.,  127  [PMID:27847171] [10.1016/j.ejmech.2016.11.018]
304. Wang C, Wu P, Tian S, Xue J, Xu L, Li H, Wei X..  (2016)  Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.,  79  (11): [PMID:27797185] [10.1021/acs.jnatprod.6b00715]
305. Travelli C, Aprile S, Rahimian R, Grolla AA, Rogati F, Bertolotti M, Malagnino F, di Paola R, Impellizzeri D, Fusco R, Mercalli V, Massarotti A, Stortini G, Terrazzino S, Del Grosso E, Fakhfouri G, Troiani MP, Alisi MA, Grosa G, Sorba G, Canonico PL, Orsomando G, Cuzzocrea S, Genazzani AA, Galli U, Tron GC..  (2017)  Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity.,  60  (5): [PMID:28165742] [10.1021/acs.jmedchem.6b01392]
306. Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW, Lightfoot-Dunn R, Hamadeh HK..  (2010)  Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.,  118  (2): [PMID:20829430] [10.1093/toxsci/kfq269]
307. Cocco M, Pellegrini C, Martínez-Banaclocha H, Giorgis M, Marini E, Costale A, Miglio G, Fornai M, Antonioli L, López-Castejón G, Tapia-Abellán A, Angosto D, Hafner-Bratkovič I, Regazzoni L, Blandizzi C, Pelegrín P, Bertinaria M..  (2017)  Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease.,  60  (9): [PMID:28410442] [10.1021/acs.jmedchem.6b01624]
308. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T..  (2012)  Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.,  40  (12): [PMID:22961681] [10.1124/dmd.112.047068]
309. Yu J, Ahn S, Kim HJ, Lee M, Ahn S, Kim J, Jin SH, Lee E, Kim G, Cheong JH, Jacobson KA, Jeong LS, Noh M..  (2017)  Polypharmacology of N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic Potential.,  60  (17): [PMID:28799755] [10.1021/acs.jmedchem.7b00805]
310. Schmidt J, Rotter M, Weiser T, Wittmann S, Weizel L, Kaiser A, Heering J, Goebel T, Angioni C, Wurglics M, Paulke A, Geisslinger G, Kahnt A, Steinhilber D, Proschak E, Merk D..  (2017)  A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis.,  60  (18): [PMID:28845983] [10.1021/acs.jmedchem.7b00398]
311. Ahn J, Chae HS, Chin YW, Kim J..  (2017)  Alkaloids from aerial parts of Houttuynia cordata and their anti-inflammatory activity.,  27  (12): [PMID:28499733] [10.1016/j.bmcl.2017.04.072]
312. Smith GF, Altman MD, Andresen B, Baker J, Brubaker JD, Chen H, Chen Y, Childers M, Donofrio A, Ferguson H, Fischer C, Fischmann TO, Gibeau C, Hicks A, Jin S, Kattar S, Kleinschek MA, Leccese E, Lesburg C, Li C, Lim J, Liu D, Maclean JKF, Mansoor F, Moy LY, Mulrooney EF, Necheva AS, Presland J, Rakhilina L, Yang R, Torres L, Zhang-Hoover J, Northrup A..  (2017)  Identification of quinazoline based inhibitors of IRAK4 for the treatment of inflammation.,  27  (12): [PMID:28501511] [10.1016/j.bmcl.2017.04.050]
313. Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK..  (2013)  A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.,  136  (1): [PMID:23956101] [10.1093/toxsci/kft176]
314. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W..  (2016)  DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.,  21  (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015]
315. Albrecht W, Unger A, Bauer SM, Laufer SA..  (2017)  Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a Dual p38α MAPK/PDE-4 Inhibitor with Activity against TNFα-Related Diseases.,  60  (13): [PMID:28613871] [10.1021/acs.jmedchem.6b01647]
316. Okon A, Han J, Dawadi S, Demosthenous C, Aldrich CC, Gupta M, Wagner CR..  (2017)  Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma.,  60  (19): [PMID:28858511] [10.1021/acs.jmedchem.7b00916]
317. Wang X, Barbosa J, Blomgren P, Bremer MC, Chen J, Crawford JJ, Deng W, Dong L, Eigenbrot C, Gallion S, Hau J, Hu H, Johnson AR, Katewa A, Kropf JE, Lee SH, Liu L, Lubach JW, Macaluso J, Maciejewski P, Mitchell SA, Ortwine DF, DiPaolo J, Reif K, Scheerens H, Schmitt A, Wong H, Xiong JM, Xu J, Zhao Z, Zhou F, Currie KS, Young WB..  (2017)  Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike Properties.,  (6): [PMID:28626519] [10.1021/acsmedchemlett.7b00103]
318. Berger M, Rehwinkel H, Schmees N, Schäcke H, Edman K, Wissler L, Reichel A, Jaroch S..  (2017)  Discovery of new selective glucocorticoid receptor agonist leads.,  27  (3): [PMID:28043796] [10.1016/j.bmcl.2016.12.047]
319. Miltz W, Velcicky J, Dawson J, Littlewood-Evans A, Ludwig MG, Seuwen K, Feifel R, Oberhauser B, Meyer A, Gabriel D, Nash M, Loetscher P..  (2017)  Design and synthesis of potent and orally active GPR4 antagonists with modulatory effects on nociception, inflammation, and angiogenesis.,  25  (16): [PMID:28689977] [10.1016/j.bmc.2017.06.050]
320. Niu B, Ke CQ, Li BH, Li Y, Yi Y, Luo Y, Shuai L, Yao S, Lin LG, Li J, Ye Y..  (2017)  Cucurbitane Glucosides from the Crude Extract of Siraitia grosvenorii with Moderate Effects on PGC-1α Promoter Activity.,  80  (5): [PMID:28448136] [10.1021/acs.jnatprod.6b01086]
321. Popović V, Goeman JL, Bougarne N, Eyckerman S, Heyerick A, De Bosscher K, Van der Eycken J..  (2017)  Involvement of the Glucocorticoid Receptor in Pro-inflammatory Transcription Factor Inhibition by Daucane Esters from Laserpitium zernyi.,  80  (5): [PMID:28489375] [10.1021/acs.jnatprod.7b00012]
322. Zhou J, Liu T, Zhang H, Zheng G, Qiu Y, Deng M, Zhang C, Yao G..  (2018)  Anti-inflammatory Grayanane Diterpenoids from the Leaves of Rhododendron molle.,  81  (1): [PMID:29272126] [10.1021/acs.jnatprod.7b00799]
323. Issa ME, Cuendet M..  (2017)  Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells.,  (1): [PMID:30108696] [10.1039/C6MD00410E]
324. Li SG, Huang XJ, Li MM, Liu Q, Liu H, Wang Y, Ye WC..  (2018)  Multiflorumisides A-G, Dimeric Stilbene Glucosides with Rare Coupling Patterns from the Roots of Polygonum multiflorum.,  81  (2): [PMID:29359942] [10.1021/acs.jnatprod.7b00540]
325. Ayoub IM, Korinek M, Hwang TL, Chen BH, Chang FR, El-Shazly M, Singab ANB..  (2018)  Probing the Antiallergic and Anti-inflammatory Activity of Biflavonoids and Dihydroflavonols from Dietes bicolor.,  81  (2): [PMID:29381070] [10.1021/acs.jnatprod.7b00476]
326. Liu S, Su M, Song SJ, Hong J, Chung HY, Jung JH..  (2018)  An Anti-Inflammatory PPAR-γ Agonist from the Jellyfish-Derived Fungus Penicillium chrysogenum J08NF-4.,  81  (2): [PMID:29389121] [10.1021/acs.jnatprod.7b00846]
327. Eräsalo H, Hämäläinen M, Leppänen T, Mäki-Opas I, Laavola M, Haavikko R, Yli-Kauhaluoma J, Moilanen E..  (2018)  Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.,  81  (5): [PMID:29726680] [10.1021/acs.jnatprod.7b00384]
328. Li R, Zhang JF, Wu YZ, Li YC, Xia GY, Wang LY, Qiu BL, Ma M, Lin S..  (2018)  Structures and Biological Evaluation of Monoterpenoid Glycosides from the Roots of Paeonia lactiflora.,  81  (5): [PMID:29741372] [10.1021/acs.jnatprod.8b00087]
329. Regenass P, Abboud D, Daubeuf F, Lehalle C, Gizzi P, Riché S, Hachet-Haas M, Rohmer F, Gasparik V, Boeglin D, Haiech J, Knehans T, Rognan D, Heissler D, Marsol C, Villa P, Galzi JL, Hibert M, Frossard N, Bonnet D..  (2018)  Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia.,  61  (17): [PMID:30106292] [10.1021/acs.jmedchem.8b00657]
330. Zimmermann-Franco DC, Esteves B, Lacerda LM, Souza IO, Santos JAD, Pinto NCC, Scio E, da Silva AD, Macedo GC..  (2018)  In vitro and in vivo anti-inflammatory properties of imine resveratrol analogues.,  26  (17): [PMID:30193941] [10.1016/j.bmc.2018.08.029]
331. Jiang Y, Li HY, Li XH, Lu J, Zhang Q, Bai CG, Chen Y..  (2018)  Therapeutic effects of isothiocyanate prodrugs on rheumatoid arthritis.,  28  (4): [PMID:29395981] [10.1016/j.bmcl.2018.01.009]
332. Wen R, Lv H, Jiang Y, Tu P..  (2018)  Anti-inflammatory isoflavones and isoflavanones from the roots of Pongamia pinnata (L.) Pierre.,  28  (6): [PMID:29482940] [10.1016/j.bmcl.2018.02.026]
333. Soares AS, Barbosa FL, Rüdiger AL, Hughes DL, Salvador MJ, Zampronio AR, Stefanello MÉA..  (2017)  Naphthoquinones of Sinningia reitzii and Anti-inflammatory/Antinociceptive Activities of 8-Hydroxydehydrodunnione.,  80  (6): [PMID:28598175] [10.1021/acs.jnatprod.6b01186]
334. Wang J, He W, Kong F, Tian X, Wang P, Zhou X, Liu Y..  (2017)  Ochracenes A-I, Humulane-Derived Sesquiterpenoids from the Antarctic Fungus Aspergillus ochraceopetaliformis.,  80  (6): [PMID:28598633] [10.1021/acs.jnatprod.6b00810]
335. Monsen PJ, Luzzio FA..  (2018)  Antiangiogenic Activity and Chemical Derivatization of the Neurotoxic Acetogenin Annonacin Isolated from Asimina triloba.,  81  (8): [PMID:30028612] [10.1021/acs.jnatprod.8b00284]
336. Ghate NB, Chaudhuri D, Panja S, Singh SS, Gupta G, Lee CY, Mandal N..  (2018)  In Vitro Mechanistic Study of the Anti-inflammatory Activity of a Quinoline Isolated from Spondias pinnata Bark.,  81  (9): [PMID:30215255] [10.1021/acs.jnatprod.8b00036]
337. Meira CS, Dos Santos Filho JM, Sousa CC, Anjos PS, Cerqueira JV, Dias Neto HA, da Silveira RG, Russo HM, Wolfender JL, Queiroz EF, Moreira DRM, Soares MBP..  (2018)  Structural design, synthesis and substituent effect of hydrazone-N-acylhydrazones reveal potent immunomodulatory agents.,  26  (8): [PMID:29523468] [10.1016/j.bmc.2018.02.047]
338. Ghoneim OM, Bill A, Dhuguru J, Szollosi DE, Edafiogho IO..  (2018)  Design, synthesis and biological evaluation of piperazino-enaminones as novel suppressants of pro-Inflammatory cytokines.,  26  (14): [PMID:29903412] [10.1016/j.bmc.2018.06.003]
339. Zhang C, Wen R, Ma XL, Zeng KW, Xue Y, Zhang PM, Zhao MB, Jiang Y, Liu GQ, Tu PF..  (2018)  Nitric Oxide Inhibitory Sesquiterpenoids and Its Dimers from Artemisia freyniana.,  81  (4): [PMID:29518326] [10.1021/acs.jnatprod.7b00947]
340. Upadhyay KD, Dodia NM, Khunt RC, Chaniara RS, Shah AK..  (2018)  Synthesis and Biological Screening of Pyrano[3,2-c]quinoline Analogues as Anti-inflammatory and Anticancer Agents.,  (3): [PMID:29541375] [10.1021/acsmedchemlett.7b00545]
341. Christodoulou MS, Dapiaggi F, Ghiringhelli F, Pieraccini S, Sironi M, Lucafò M, Curci D, Decorti G, Stocco G, Chirumamilla CS, Vanden Berghe W, Balaguer P, Michel BY, Burger A, Beccalli EM, Passarella D, Martinet N..  (2018)  Imidazo[2,1-b]benzothiazol Derivatives as Potential Allosteric Inhibitors of the Glucocorticoid Receptor.,  (4): [PMID:29670697] [10.1021/acsmedchemlett.7b00527]
342. Zheng JX, Han YS, Wang JC, Yang H, Kong H, Liu KJ, Chen SY, Chen YR, Chang YQ, Chen WM, Guo JL, Sun PH..  (2018)  Strigolactones: a plant phytohormone as novel anti-inflammatory agents.,  (1): [PMID:30108912] [10.1039/C7MD00461C]
343. Sampathi Perera KLI, Hanson AM, Lindeman S, Imhoff A, Lu X, Sem DS, Donaldson WA..  (2018)  Synthesis and evaluation of 4-cycloheptylphenols as selective Estrogen receptor-β agonists (SERBAs).,  157  [PMID:30144697] [10.1016/j.ejmech.2018.08.006]
344. Dumontet C, Beck G, Gardebien F, Haudecoeur R, Mathé D, Matera EL, Tourette A, Mattei E, Esmenjaud J, Boyère C, Nurisso A, Peuchmaur M, Pérès B, Bouchaud G, Magnan A, Monneret G, Boumendjel A..  (2018)  Piperidinyl-embeded chalcones possessing anti PI3Kδ inhibitory properties exhibit anti-atopic properties in preclinical models.,  158  [PMID:30237123] [10.1016/j.ejmech.2018.09.033]
345. Pathania S, Rawal RK..  (2018)  Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes.,  157  [PMID:30114661] [10.1016/j.ejmech.2018.08.023]
346. Moraes ADTO, Miranda MDS, Jacob ÍTT, Amorim CADC, Moura RO, Silva SÂSD, Soares MBP, Almeida SMV, Souza TRCL, Oliveira JF, Silva TGD, Melo CML, Moreira DRM, Lima MDCA..  (2018)  Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives.,  26  (20): [PMID:30293795] [10.1016/j.bmc.2018.07.024]
347. Unpublished dataset, 
348. Feng L, Zhang Y, Liu YC, Liu Y, Luo SH, Huang CS, Li SH..  (2019)  Leucoflavonine, a new bioactive racemic flavoalkaloid from the leaves of Leucosceptrum canum.,  27  (2): [PMID:30579802] [10.1016/j.bmc.2018.12.023]
349. Su XD, Jang HJ, Wang CY, Lee SW, Rho MC, Kim YH, Yang SY..  (2019)  Anti-inflammatory Potential of Saponins from Aster tataricus via NF-κB/MAPK Activation.,  82  (5): [PMID:30931559] [10.1021/acs.jnatprod.8b00856]
350. Egbert M, Whitty A, Keserű GM, Vajda S..  (2019)  Why Some Targets Benefit from beyond Rule of Five Drugs.,  62  (22): [PMID:31188592] [10.1021/acs.jmedchem.8b01732]
351. Fang J, Cai C, Chai Y, Zhou J, Huang Y, Gao L, Wang Q, Cheng F..  (2019)  Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease.,  161  [PMID:30359818] [10.1016/j.ejmech.2018.10.020]
352. Yao X, Sun X, Jin S, Yang L, Xu H, Rao Y..  (2019)  Discovery of 4-Aminoquinoline-3-carboxamide Derivatives as Potent Reversible Bruton's Tyrosine Kinase Inhibitors for the Treatment of Rheumatoid Arthritis.,  62  (14): [PMID:31260299] [10.1021/acs.jmedchem.9b00329]
353. Su JC, Cheng W, Song JG, Zhong YL, Huang XJ, Jiang RW, Li YL, Li MM, Ye WC, Wang Y..  (2019)  Macrocyclic Diterpenoids from Euphorbia helioscopia and Their Potential Anti-inflammatory Activity.,  82  (10): [PMID:31550154] [10.1021/acs.jnatprod.9b00519]
354. Wang GK, Zhang N, Yao JN, Yu Y, Wang G, Hung CC, Cheng YY, Morris-Natschke SL, Zhou ZY, Liu JS, Lee KH..  (2019)  Kalshinoids A-F, Anti-inflammatory Sesquiterpenes from Kalimeris shimadae.,  82  (12): [PMID:31804830] [10.1021/acs.jnatprod.9b00693]
355. Feng L, Wang J, Liu S, Zhang XJ, Bi QR, Hu YY, Wang Z, Tan NH..  (2019)  Colletopeptides A-D, Anti-inflammatory Cyclic Tridepsipeptides from the Plant Endophytic Fungus Colletotrichum sp. S8.,  82  (6): [PMID:31181925] [10.1021/acs.jnatprod.8b00829]
356. Zeferino-Díaz R, Olivera-Castillo L, Dávalos A, Grant G, Kantún-Moreno N, Rodriguez-Canul R, Bernès S, Sandoval-Ramírez J, Fernández-Herrera MA..  (2019)  22-Oxocholestane oximes as potential anti-inflammatory drug candidates.,  168  [PMID:30798054] [10.1016/j.ejmech.2019.02.035]
357. Crane EA, Heydenreuter W, Beck KR, Strajhar P, Vomacka J, Smiesko M, Mons E, Barth L, Neuburger M, Vedani A, Odermatt A, Sieber SA, Gademann K..  (2019)  Profiling withanolide A for therapeutic targets in neurodegenerative diseases.,  27  (12): [PMID:30929949] [10.1016/j.bmc.2019.03.022]
358. Chokchaisiri R, Chaichompoo W, Chunglok W, Cheenpracha S, Ganranoo L, Phutthawong N, Bureekaew S, Suksamrarn A..  (2020)  Isopimarane Diterpenoids from the Rhizomes of Kaempferia marginata and Their Potential Anti-inflammatory Activities.,  83  (1): [PMID:31873014] [10.1021/acs.jnatprod.9b00307]
359. Shaikh NS, Iyer JP, Munot YS, Mukhopadhyay PP, Raje AA, Nagaraj R, Jamdar V, Gavhane R, Lohote M, Sherkar P, Bala M, Petla R, Meru A, Umrani D, Rouduri S, Joshi S, Reddy S, Kandikere V, Bhuniya D, Kulkarni B, Mookhtiar KA..  (2019)  Discovery and pharmacological evaluation of indole derivatives as potent and selective RORγt inverse agonist for multiple autoimmune conditions.,  29  (16): [PMID:31272795] [10.1016/j.bmcl.2019.06.044]
360. Babkov DA, Zhukowskaya ON, Borisov AV, Babkova VA, Sokolova EV, Brigadirova AA, Litvinov RA, Kolodina AA, Morkovnik AS, Sochnev VS, Borodkin GS, Spasov AA..  (2019)  Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators.,  29  (17): [PMID:31358465] [10.1016/j.bmcl.2019.07.035]
361. Borazjani N, Sepehri S, Behzadi M, Jarrahpour A, Rad JA, Sasanipour M, Mohkam M, Ghasemi Y, Akbarizadeh AR, Digiorgio C, Brunel JM, Ghanbari MM, Batta G, Turos E..  (2019)  Three-component synthesis of chromeno β-lactam hybrids for inflammation and cancer screening.,  179  [PMID:31260892] [10.1016/j.ejmech.2019.06.036]
362. Huang Y, Zhang B, Li J, Liu H, Zhang Y, Yang Z, Liu W..  (2019)  Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX.,  180  [PMID:31299586] [10.1016/j.ejmech.2019.07.004]
363. Wu Q, Li XW, Li H, Yao LG, Tang W, Miao ZH, Wang H, Guo YW..  (2019)  Bioactive polyoxygenated cembranoids from a novel Hainan chemotype of the soft coral Sinularia flexibilis.,  29  (2): [PMID:30528697] [10.1016/j.bmcl.2018.12.004]
364. Mota FVB, de Araújo Neta MS, de Souza Franco E, Bastos IVGA, da Araújo LCC, da Silva SC, de Oliveira TB, Souza EK, de Almeida VM, Ximenes RM, de Sousa Maia MB, Junior FJBM, Marchand P, de Faria AR, da Silva TG..  (2019)  Evaluation of anti-inflammatory activity and molecular docking study of new aza-bicyclic isoxazoline acylhydrazone derivatives.,  10  (11): [PMID:32133104] [10.1039/C9MD00276F]
365. de Gaetano M, Butler E, Gahan K, Zanetti A, Marai M, Chen J, Cacace A, Hams E, Maingot C, McLoughlin A, Brennan E, Leroy X, Loscher CE, Fallon P, Perretti M, Godson C, Guiry PJ..  (2019)  Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms).,  162  [PMID:30419493] [10.1016/j.ejmech.2018.10.049]
366. Ba Vinh L, Jang HJ, Viet Phong N, Dan G, Won Cho K, Ho Kim Y, Young Yang S..  (2019)  Bioactive triterpene glycosides from the fruit of Stauntonia hexaphylla and insights into the molecular mechanism of its inflammatory effects.,  29  (16): [PMID:31301930] [10.1016/j.bmcl.2019.07.010]
367. Shao SY, Yang YN, Feng ZM, Jiang JS, Zhang PC..  (2019)  Anti-inflammatory phenylpropanoid glycosides from the fruits of Forsythia suspensa.,  29  (19): [PMID:31473042] [10.1016/j.bmcl.2019.126635]
368. Vinh LB, Jang HJ, Phong NV, Cho K, Park SS, Kang JS, Kim YH, Yang SY..  (2019)  Isolation, structural elucidation, and insights into the anti-inflammatory effects of triterpene saponins from the leaves of Stauntonia hexaphylla.,  29  (8): [PMID:30808589] [10.1016/j.bmcl.2019.02.022]
369. Ju Z, Su M, Hong J, La Kim E, Moon HR, Chung HY, Kim S, Jung JH..  (2019)  Design of balanced COX inhibitors based on anti-inflammatory and/or COX-2 inhibitory ascidian metabolites.,  180  [PMID:31301566] [10.1016/j.ejmech.2019.07.016]
370. Luan ZL, Huo XK, Dong PP, Tian XG, Sun CP, Lv X, Feng L, Ning J, Wang C, Zhang BJ, Ma XC..  (2019)  Highly potent non-steroidal FXR agonists protostane-type triterpenoids: Structure-activity relationship and mechanism.,  182  [PMID:31494470] [10.1016/j.ejmech.2019.111652]
371. Chen Y, Chen WN, Hu N, Banwell MG, Ma C, Gardiner MG, Lan P..  (2019)  Cytotoxicity and Anti-inflammatory Properties of Apigenin-Derived Isolaxifolin.,  82  (9): [PMID:31465218] [10.1021/acs.jnatprod.9b00113]
372. Wang L, Yang X, Zhang Y, Chen R, Cui Y, Wang Q..  (2019)  Anti-inflammatory Chalcone-Isoflavone Dimers and Chalcone Dimers from Caragana jubata.,  82  (10): [PMID:31577434] [10.1021/acs.jnatprod.9b00365]
373.  (2017)  Arf6 inhibitors and methods of synthesis and use thereof, 
374. Zhang CY, Wu YL, Zhang P, Chen ZZ, Li H, Chen LX..  (2019)  Anti-inflammatory Lathyrane Diterpenoids from Euphorbia lathyris.,  82  (4): [PMID:30817151] [10.1021/acs.jnatprod.8b00600]
375. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of NIH (USA) - Clinical Collection,  [10.6019/CHEMBL4513141]
376. Chen HP, Zhao ZZ, Cheng GG, Zhao K, Han KY, Zhou L, Feng T, Li ZH, Liu JK..  (2020)  Immunosuppressive Nor-isopimarane Diterpenes from Cultures of the Fungicolous Fungus Xylaria longipes HFG1018.,  83  (2): [PMID:31961677] [10.1021/acs.jnatprod.9b00889]
377. Gonçalves ECD, Assis PM, Junqueira LA, Cola M, Santos ARS, Raposo NRB, Dutra RC..  (2020)  Citral Inhibits the Inflammatory Response and Hyperalgesia in Mice: The Role of TLR4, TLR2/Dectin-1, and CB2 Cannabinoid Receptor/ATP-Sensitive K+ Channel Pathways.,  83  (4): [PMID:32150408] [10.1021/acs.jnatprod.9b01134]
378. Yang WJ, Chen XM, Wang SQ, Hu HX, Cheng XP, Xu LT, Ren DM, Wang XN, Zhao BB, Lou HX, Shen T..  (2020)  4β-Hydroxywithanolide E from Goldenberry (Whole Fruits of Physalis peruviana L.) as a Promising Agent against Chronic Obstructive Pulmonary Disease.,  83  (4): [PMID:32159343] [10.1021/acs.jnatprod.9b01265]
379. Gege C, Albers M, Kinzel O, Kleymann G, Schlüter T, Steeneck C, Hoffmann T, Xue X, Cummings MD, Spurlino J, Milligan C, Fourie AM, Edwards JP, Leonard K, Coe K, Scott B, Pippel D, Goldberg SD..  (2020)  Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt.,  30  (12): [PMID:32336498] [10.1016/j.bmcl.2020.127205]
380. Anuchapreeda S, Anzawa R, Viriyaadhammaa N, Neimkhum W, Chaiyana W, Okonogi S, Usuki T..  (2020)  Isolation and biological activity of agrostophillinol from kaffir lime (Citrus hystrix) leaves.,  30  (14): [PMID:32527555] [10.1016/j.bmcl.2020.127256]
381. Sakai H, Inoue H, Murata K, Toba T, Shimmyo Y, Narii N, Ueno SY, Igawa Y, Takemoto N..  (2020)  Fibroblast growth factor receptor modulators employing diamines with reduced phospholipidosis-inducing potential.,  28  (14): [PMID:32616184] [10.1016/j.bmc.2020.115562]
382. Berger M, May E, Rehwinkel H, Schäcke H, Neuhaus R, Rottmann A, Zollner TM, Jaroch S..  (2020)  Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidate.,  30  (16): [PMID:32631518] [10.1016/j.bmcl.2020.127298]
383. Nair S, Kumar SR, Paidi VR, Sistla R, Kantheti D, Polimera SR, Thangavel S, Mukherjee AJ, Das M, Bhide RS, Pitts WJ, Murugesan N, Dudhgoankar S, Nagar J, Subramani S, Mazumder D, Carman JA, Holloway DA, Li X, Fereshteh MP, Ruepp S, Palanisamy K, Mariappan TT, Maddi S, Saxena A, Elzinga P, Chimalakonda A, Ruan Q, Ghosh K, Bose S, Sack J, Yan C, Kiefer SE, Xie D, Newitt JA, Saravanakumar SP, Rampulla RA, Barrish JC, Carter PH, Hynes J..  (2020)  Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis.,  11  (7): [PMID:32676146] [10.1021/acsmedchemlett.0c00082]
384. Zhang JS, Cao XX, Yu JH, Yu ZP, Zhang H..  (2020)  Diarylheptanoids with NO production inhibitory activity from Amomum kravanh.,  30  (8): [PMID:32070636] [10.1016/j.bmcl.2020.127026]
385. Pereira LCO, Abreu LS, Silva JPRE, Machado FSVL, Queiroga CS, do Espı Rito-Santo RF, Agnelo-Silva DF, Villarreal CF, Agra MF, Scotti MT, Costa VCO, Tavares JF, Silva MSD..  (2020)  Bioactive Compounds from the Aerial Parts of Evolvulus linarioides.,  83  (5): [PMID:32364737] [10.1021/acs.jnatprod.9b01189]
386. Unpublished dataset, 
387. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]
388. Yang SM,Yoshioka M,Strovel JW,Urban DJ,Hu X,Hall MD,Jadhav A,Maloney DJ.  (2019)  Lead optimization and efficacy evaluation of quinazoline-based BET family inhibitors for potential treatment of cancer and inflammatory diseases.,  29  (10.0): [PMID:30905542] [10.1016/j.bmcl.2019.03.014]
389. Zhang YY,Zhang QQ,Zhang J,Song JL,Li JC,Han K,Huang JT,Jiang CS,Zhang H.  (2020)  Synthesis and evaluation of 1,2,4-oxadiazole derivatives as potential anti-inflammatory agents by inhibiting NF-κB signaling pathway in LPS-stimulated RAW 264.7 cells.,  30  (17.0): [PMID:32738985] [10.1016/j.bmcl.2020.127373]
390. Zhang XJ,Zhong WM,Liu RX,Wang YM,Luo T,Zou Y,Qin HY,Li XL,Zhang R,Xiao WL.  (2020)  Structurally Diverse Labdane Diterpenoids from Leonurus japonicus and Their Anti-inflammatory Properties in LPS-Induced RAW264.7 Cells.,  83  (9.0): [PMID:32935986] [10.1021/acs.jnatprod.9b00597]
391. Radulović NS,Filipović SI,Nešić MS,Stojanović NM,Mitić KV,Mladenović MZ,Ranđelović VN.  (2020)  Immunomodulatory Constituents of Conocephalum conicum (Snake Liverwort) and the Relationship of Isolepidozenes to Germacranes and Humulanes.,  83  (12): [PMID:33264011] [10.1021/acs.jnatprod.0c00585]
392. Zimmerman, Jessica A. O., Fang, Mimi, Doumbia, Bintou, Neyman, Alexis, Cha, Ji Hyeon, Thomas, Michael, Hall, Bonnie, Wu, Meng, Wilson, Anne M., Pufall, Miles A..  (2021)  Deacylcortivazol-like pyrazole regioisomers reveal a more accommodating expanded binding pocket for the glucocorticoid receptor,  12  (2): [PMID:34046609] [10.1039/d0md00278j]
393. Xiao HY,Watterson SH,Langevine CM,Srivastava AS,Ko SS,Zhang Y,Cherney RJ,Guo WW,Gilmore JL,Sheppeck JE,Wu DR,Li P,Ramasamy D,Arunachalam P,Mathur A,Taylor TL,Shuster DJ,McIntyre KW,Shen DR,Yarde M,Cvijic ME,Marino AM,Balimane PV,Yang Z,Banas DM,Cornelius G,D'Arienzo CJ,Warrack BM,Lehman-McKeeman L,Salter-Cid LM,Xie J,Barrish JC,Carter PH,Dyckman AJ,Dhar TG.  (2016)  Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P) Employing Ligand-Based Drug Design.,  59  (21): [PMID:27726358] [10.1021/acs.jmedchem.6b01099]
394. Sun,N.; Ma,X.; Zhou,K.; Zhu,C.; Cao,Z.; Wang,Y.; Xu,J.; Fu,W..  (2020)  Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases.,  187  [PMID:31881455] [10.1016/j.ejmech.2019.111984]
395. Lu MC,Shao HL,Liu T,You QD,Jiang ZY.  (2020)  Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions.,  207  [PMID:32866756] [10.1016/j.ejmech.2020.112734]
396. Balasubramanian G,Narayanan S,Andiappan L,Sappanimuthu T,Thirunavukkarasu S,Sundaram S,Natarajan S,Sivaraman N,Rajagopal S,Nazumudeen FAA,Saxena S,Vishwakarma SL,Narayanan S,Sharma GVR,Srinivasan CV,Kilambi N.  (2016)  In vivo effective dibenzo[b,d]furan-1-yl-thiazoles as novel PDE-4 inhibitors.,  24  (22.0): [PMID:27713015] [10.1016/j.bmc.2016.09.011]
397. Wang L,Lei W,Zhang S,Yao L.  (2021)  MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice.,  30  [PMID:33360197] [10.1016/j.bmc.2020.115954]
398. Chen LZ, Shu HY, Wu J, Yu YL, Ma D, Huang X, Liu MM, Liu XH, Shi JB..  (2021)  Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis.,  213  [PMID:33515864] [10.1016/j.ejmech.2021.113174]
399. Guan B, Jiang C..  (2021)  Design and development of 1,3,5-triazine derivatives as protective agent against spinal cord injury in rat via inhibition of NF-ĸB.,  41  [PMID:33744436] [10.1016/j.bmcl.2021.127964]
400. Mezeiova E, Janockova J, Andrys R, Soukup O, Kobrlova T, Muckova L, Pejchal J, Simunkova M, Handl J, Micankova P, Capek J, Rousar T, Hrabinova M, Nepovimova E, Marco-Contelles JL, Valko M, Korabecny J..  (2021)  2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease.,  211  [PMID:33360800] [10.1016/j.ejmech.2020.113112]
401. Watanabe R, Esaki T, Ohashi R, Kuroda M, Kawashima H, Komura H, Natsume-Kitatani Y, Mizuguchi K..  (2021)  Development of an In Silico Prediction Model for P-glycoprotein Efflux Potential in Brain Capillary Endothelial Cells toward the Prediction of Brain Penetration.,  64  (5.0): [PMID:33619967] [10.1021/acs.jmedchem.0c02011]
402. Zhang DL, Li M, Han GF, Li SY, Jin DJ, Tang SA..  (2021)  Longipetalol A: A Highly Modified Triterpenoid from Dichapetalum longipetalum.,  84  (5.0): [PMID:33914536] [10.1021/acs.jnatprod.1c00068]
403. Papa P, Whitefield B, Mortensen DS, Cashion D, Huang D, Torres E, Parnes J, Sapienza J, Hansen J, Correa M, Delgado M, Harris R, Hegde S, Norris S, Bahmanyar S, Plantevin-Krenitsky V, Liu Z, Leftheris K, Kulkarni A, Bennett B, Hur EM, Ringheim G, Khambatta G, Chan H, Muir J, Blease K, Burnett K, LeBrun L, Morrison L, Celeridad M, Khattri R, Cathers BE..  (2021)  Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005.,  64  (16.0): [PMID:34355886] [10.1021/acs.jmedchem.1c00388]
404. Zhang Z, Wang H, Yuan J, Li X, Fang N, Lin M, Hou Q, Ji T..  (2021)  Design, synthesis, and pharmacological evaluation of sinomenine derivatives on rings A and C: Novel compounds screening for aplastic anemia targeting on cytotoxic T lymphocyte.,  225  [PMID:34450495] [10.1016/j.ejmech.2021.113791]
405. Wang M, Yu S, Qi S, Zhang B, Song K, Liu T, Gao H..  (2021)  Anti-inflammatory Cassane-Type Diterpenoids from the Seed Kernels of Caesalpinia sinensis.,  84  (8.0): [PMID:34333975] [10.1021/acs.jnatprod.1c00233]
406. Tan X, Han X, Teng H, Li Q, Chen Y, Lei X, Yang G..  (2021)  Structural Elucidation of Garcipaucinones A and B From Garcinia paucinervis Using Quantum Chemical Calculations.,  84  (4.0): [PMID:33667092] [10.1021/acs.jnatprod.0c00883]
407. Kennedy BJ, Lato AM, Fisch AR, Burke SJ, Kirkland JK, Prevatte CW, Dunlap LE, Smith RT, Vogiatzis KD, Collier JJ, Campagna SR..  (2021)  Potent Anti-Inflammatory, Arylpyrazole-Based Glucocorticoid Receptor Agonists That Do Not Impair Insulin Secretion.,  12  (10.0): [PMID:34676039] [10.1021/acsmedchemlett.1c00379]
408. Du F, Sun W, Morisseau C, Hammock BD, Bao X, Liu Q, Wang C, Zhang T, Yang H, Zhou J, Xiao W, Liu Z, Chen G..  (2021)  Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.,  223  [PMID:34218083] [10.1016/j.ejmech.2021.113678]
409. Potenza M, Sciarretta M, Chini MG, Saviano A, Maione F, D'Auria MV, De Marino S, Giordano A, Hofstetter RK, Festa C, Werz O, Bifulco G..  (2021)  Structure-based screening for the discovery of 1,2,4-oxadiazoles as promising hits for the development of new anti-inflammatory agents interfering with eicosanoid biosynthesis pathways.,  224  [PMID:34315041] [10.1016/j.ejmech.2021.113693]
410. Chen J, Li L, Liu J, Yuan S, Liao W, Slominski AT, Li W, Żmijewski MA, Chen J..  (2021)  Discovery of novel 3-hydroxyandrosta-5,7-Diene-17-Carboxylic acid derivatives as anti-inflammatory bowel diseases (IBD) agents.,  220  [PMID:33933753] [10.1016/j.ejmech.2021.113468]
411. de Gaetano M, Tighe C, Gahan K, Zanetti A, Chen J, Newson J, Cacace A, Marai M, Gaffney A, Brennan E, Kantharidis P, Cooper ME, Leroy X, Perretti M, Gilroy D, Godson C, Guiry PJ..  (2021)  Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A4 Mimetics (QNX-sLXms).,  64  (13.0): [PMID:34138563] [10.1021/acs.jmedchem.1c00403]
412. Zeng HT, Yu YH, Zeng X, Li MM, Li X, Xu SS, Tu ZC, Yuan T..  (2022)  Anti-inflammatory Dimeric Benzophenones from an Endophytic Pleosporales Species.,  85  (1.0): [PMID:35007071] [10.1021/acs.jnatprod.1c00900]
413.  (2021)  Arf6 inhibitors and related methods, 
414. Boness HVM, de Oliveira MS, Batista CSC, Almeida LS, Boffo EF, Villarreal CF, Cruz FG..  (2021)  Anti-Inflammatory and Antinociceptive Properties of Kielmeyerone A, a Chromenone Isolated from the Roots of Kielmeyera reticulata.,  84  (8.0): [PMID:34283606] [10.1021/acs.jnatprod.1c00157]
415.  (2022)  Tm Shift (DSF) assay results for EUbOPEN Chemogenomis Library 2 (Incucyte),  [10.6019/CHEMBL5058564]
416.  (2022)  Tm Shift (DSF) assay results for EUbOPEN Chemogenomis Library 2 (Multiplex),  [10.6019/CHEMBL5058577]
417. EUbOPEN.  (2022)  EUbOPEN Chemogenomics Library wave 2 - DSF,  [10.6019/CHEMBL5060014]
418. Xia W, Kolli AR, Koshibu K, Martin F, Kondylis A, Kuczaj A, Tan WT, Yeo YS, Tan G, Teng C, Woon K, Schneider T, Talikka M, Phillips BW, Vanscheeuwijck P, Peitsch MC, Hoeng J..  (2021)  In Vivo Profiling of a Natural Alkaloid, Anatabine, in Rodents: Pharmacokinetics and Anti-Inflammatory Efficacy.,  84  (4.0): [PMID:33706515] [10.1021/acs.jnatprod.0c01044]
419. Wang J, Wei W, Zhang X, Cao S, Hu B, Ye Y, Jiang M, Wang T, Zuo J, He S, Yang C..  (2021)  Synthesis and Biological Evaluation of C-17-Amino-Substituted Pyrazole-Fused Betulinic Acid Derivatives as Novel Agents for Osteoarthritis Treatment.,  64  (18.0): [PMID:34491054] [10.1021/acs.jmedchem.1c01019]
420. Łowicki D, Przybylski P..  (2022)  Cascade synthetic strategies opening access to medicinal-relevant aliphatic 3- and 4-membered N-heterocyclic scaffolds.,  238  [PMID:35567964] [10.1016/j.ejmech.2022.114438]
421. Mlakić M, Odak I, Faraho I, Talić S, Bosnar M, Lasić K, Barić D, Škorić I..  (2022)  New naphtho/thienobenzo-triazoles with interconnected anti-inflammatory and cholinesterase inhibitory activity.,  241  [PMID:35870364] [10.1016/j.ejmech.2022.114616]
422. Jiang L, Xu L, Zheng L, Wang Y, Zhuang M, Yang D..  (2022)  Salidroside attenuates sepsis-associated acute lung injury through PPP1R15A mediated endoplasmic reticulum stress inhibition.,  71  [PMID:35985062] [10.1016/j.bmc.2022.116865]
423. Hu X, Pang J, Chen C, Jiang D, Shen C, Chai X, Yang L, Zhang X, Xu L, Cui S, Hou T, Li D..  (2022)  Discovery of novel non-steroidal selective glucocorticoid receptor modulators by structure- and IGN-based virtual screening, structural optimization, and biological evaluation.,  237  [PMID:35483323] [10.1016/j.ejmech.2022.114382]
424. Lin Y, Wongkrajang K, Shen X, Wang P, Zhou Z, Chuprajob T, Sornkaew N, Yang N, Yang L, Lu X, Chokchaisiri R, Suksamrarn A, Zhang G, Wang F..  (2022)  Discovery of diarylheptanoids that activate α7 nAchR-JAK2-STAT3 signaling in macrophages with anti-inflammatory activity in vitro and in vivo.,  66  [PMID:35576655] [10.1016/j.bmc.2022.116811]
425. Hasriadi, Wasana PWD, Sritularak B, Vajragupta O, Rojsitthisak P, Towiwat P..  (2022)  Batatasin III, a Constituent of Dendrobium scabrilingue, Improves Murine Pain-like Behaviors with a Favorable CNS Safety Profile.,  85  (7.0): [PMID:35707966] [10.1021/acs.jnatprod.2c00376]
426. Lato AM, Burke SJ, Ducote MP, Kennedy BJ, Collier JJ, Campagna SR..  (2022)  Stereoisomers of an Aryl Pyrazole Glucocorticoid Receptor Agonist Scaffold Elicit Differing Anti-inflammatory Responses.,  13  (9.0): [PMID:36105346] [10.1021/acsmedchemlett.2c00299]
427. E Silva JPR, Pereira LCO, Abreu LS, Lins FSV, de Souza TA, do Espírito-Santo RF, Barros RPC, Villarreal CF, de Melo JIM, Scotti MT, Costa VCO, Martorano LH, Dos Santos FM, Filho RB, da Silva MS, Tavares JF..  (2022)  Targeted Isolation of Anti-inflammatory Lignans from Justicia aequilabris by Molecular Networking Approach.,  85  (9.0): [PMID:35998343] [10.1021/acs.jnatprod.2c00478]
428. Shim S, Krishnaiah M, Sankham MR, Kim I, Lee Y, Shin I, Oh AR, Lee HJ, Vu TNL, Park J, Choi S, Park S, Kwon Y, Fang S, Kim DK..  (2022)  Discovery of (E)-3-(3-((2-Cyano-4'-dimethylaminobiphenyl-4-ylmethyl)cyclohexanecarbonylamino)-5-fluorophenyl)acrylic Acid Methyl Ester, an Intestine-Specific, FXR Partial Agonist for the Treatment of Nonalcoholic Steatohepatitis.,  65  (14.0): [PMID:35797110] [10.1021/acs.jmedchem.2c00641]
429. Wang YH, Zhou MZ, Ye T, Wang PP, Lu R, Wang YL, Liu CX, Xiao W, Li JY, Meng ZB, Xu LL, Hu QH, Jiang C..  (2022)  Discovery of a Series of 5-Amide-1H-pyrazole-3-carboxyl Derivatives as Potent P2Y14R Antagonists with Anti-Inflammatory Characters.,  65  (23.0): [PMID:36394994] [10.1021/acs.jmedchem.2c01632]
430. Wang W, Xiong L, Li Y, Song Z, Sun D, Li H, Chen L..  (2022)  Synthesis of lathyrane diterpenoid nitrogen-containing heterocyclic derivatives and evaluation of their anti-inflammatory activities.,  56  [PMID:35063896] [10.1016/j.bmc.2022.116627]
431. EUbOPEN.  (2023)  GPCR results for EUbOPEN Chemogenomics Library 3,  [10.6019/CHEMBL5209801]
432. Chen P, Yu Y, Su S, Du Z, Cai B, Sun X, Chattipakorn N, Samorodov AV, Pavlov VN, Tang Q, Cho WJ, Liang G..  (2023)  Design, synthesis, and bioactivity evaluation of novel 1-(4-(benzylsulfonyl)-2-nitrophenyl) derivatives as potential anti-inflammatory agents against LPS-induced acute lung injury.,  80  [PMID:36462751] [10.1016/j.bmcl.2022.129097]
433. Potenza M, Giordano A, Chini MG, Saviano A, Kretzer C, Raucci F, Russo M, Lauro G, Terracciano S, Bruno I, Iorizzi M, Hofstetter RK, Pace S, Maione F, Werz O, Bifulco G..  (2023)  Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors.,  14  (1.0): [PMID:36655121] [10.1021/acsmedchemlett.2c00343]
434. Bai R, Yao C, Zhong Z, Ge J, Bai Z, Ye X, Xie T, Xie Y..  (2021)  Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation.,  213  [PMID:33454546] [10.1016/j.ejmech.2021.113165]
435. Sharma S, Kumar D, Singh G, Monga V, Kumar B..  (2020)  Recent advancements in the development of heterocyclic anti-inflammatory agents.,  200  [PMID:32485533] [10.1016/j.ejmech.2020.112438]
436. Li D, Bao X, Pang J, Hu X, Wang L, Wang J, Yang Z, Xu L, Wang S, Weng Q, Cui S, Hou T..  (2022)  Discovery and Optimization of N-Acyl-6-sulfonamide-tetrahydroquinoline Derivatives as Novel Non-Steroidal Selective Glucocorticoid Receptor Modulators.,  65  (23.0): [PMID:36399795] [10.1021/acs.jmedchem.2c01082]
437. Hammouda MM, Gaffer HE, Elattar KM..  (2022)  Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-a]pyrimidine scaffold.,  13  (10.0): [PMID:36325400] [10.1039/d2md00192f]
438. Guo Y, Hu N, Liu Y, Zhang W, Yu D, Shi G, Zhang B, Yin L, Wei M, Yuan X, Luo L, Wang F, Song X, Xin L, Wei Q, Li Y, Guo Y, Chen S, Zhang T, Zhang S, Zhou X, Zhang C, Su D, Liu J, Cheng Z, Zhang J, Xing H, Sun H, Li X, Zhao Y, He M, Wu Y, Guo Y, Sun X, Tian A, Zhou C, Young S, Liu X, Wang L, Wang Z..  (2023)  Discovery of BGB-8035, a Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase for B-Cell Malignancies and Autoimmune Diseases.,  66  (6): [PMID:36912866] [10.1021/acs.jmedchem.2c01938]
439. Puhl AC, Fernandes RS, Godoy AS, Gil LHVG, Oliva G, Ekins S..  (2023)  The protein disulfide isomerase inhibitor 3-methyltoxoflavin inhibits Chikungunya virus.,  83  [PMID:36940609] [10.1016/j.bmc.2023.117239]
440. Wang W, Liu Y, Xiong L, Sun D, Wang H, Song Z, Li Y, Li H, Chen L..  (2023)  Synthesis of Lathyrol PROTACs and Evaluation of Their Anti-Inflammatory Activities.,  86  (4): [PMID:37002536] [10.1021/acs.jnatprod.2c00912]
441. Kumar K, Das R, Thapa B, Rakhecha B, Srivastava S, Savita K, Israr M, Chanda D, Banerjee D, Shanker K, Bawankule DU, Santini B, Di Paolo ML, Via LD, Passarella D, Negi AS..  (2023)  Dual targeted 2-Benzylideneindanone pendant hydroxamic acid group exhibits selective HDAC6 inhibition along with tubulin stabilization effect.,  86  [PMID:37146520] [10.1016/j.bmc.2023.117300]
442. Nehra B, Rulhania S, Jaswal S, Kumar B, Singh G, Monga V..  (2020)  Recent advancements in the development of bioactive pyrazoline derivatives.,  205  [PMID:32795767] [10.1016/j.ejmech.2020.112666]
443. Sutherland JJ, Yonchev D, Fekete A, Urban L..  (2023)  A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.,  14  (1): [PMID:37468498] [10.1038/s41467-023-40064-9]
444. European Medicines Agency,